<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00121641</url>
  </required_header>
  <id_info>
    <org_study_id>CV181-011</org_study_id>
    <nct_id>NCT00121641</nct_id>
  </id_info>
  <brief_title>Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise</brief_title>
  <official_title>A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial to Evaluate the Efficacy and Safety of Saxagliptin (BMS-477118) as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AstraZeneca</source>
  <brief_summary>
    <textblock>
      The purpose of this clinical research study is to learn whether saxagliptin (BMS-477118) is
      more effective than placebo as a treatment for type 2 diabetic subjects who are not
      sufficiently controlled with diet and exercise
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All subjects will participate in a lead-in period, and qualifying subjects will continue into
      a short-term randomized treatment period. Subjects who complete the short-term period will be
      eligible to enter the long term extension period. Also, subjects in the short-term period who
      have an elevated blood sugar that requires additional medication for blood sugar control will
      be eligible to enter the long-term treatment extension period where they will receive
      metformin added onto their blinded study medication. Subjects with screening hemoglobin A1c
      (A1C) &gt; 10.0% and ≤ 12.0%, who otherwise meet all inclusion/exclusion criteria, were eligible
      to enroll directly into Open-Label Treatment Cohort (Direct Enrollees) and receive open-label
      saxagliptin 10 mg. Those who completed the short-term period were eligible to enter into the
      long-term treatment extension period.Saxagliptin dose titration was not permitted.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2005</start_date>
  <completion_date type="Actual">February 2010</completion_date>
  <primary_completion_date type="Actual">August 2006</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hemoglobin A1c (A1C) Changes From Baseline at Week 24</measure>
    <time_frame>Baseline, Week 24</time_frame>
    <description>To compare the change from baseline in HbA1c achieved with each dose of saxagliptin versus placebo in treatment naive subjects with type 2 diabetes who have inadequate glycemic control defined as A1C ≥7.0% and ≤10.0%.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>A1C Changes From Baseline at Week 24 - Open Label Cohort</measure>
    <time_frame>Baseline, Week 24</time_frame>
    <description>To compare the change from baseline in HbA1c achieved with each dose of saxagliptin versus placebo in treatment naive subjects with type 2 diabetes who have inadequate glycemic control defined as A1C ≥7.0% and ≤10.0%.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Baseline and Change From Baseline at Week 24 in Fasting Plasma Glucose (FPG)</measure>
    <time_frame>Baseline, Week 24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Achieving Therapeutic Glycemic Response (A1C &lt; 7.0%) at Week 24</measure>
    <time_frame>Week 24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baseline and Change From Baseline at Week 24 in Postprandial Glucose (PPG) Area Under the Curve (AUC)</measure>
    <time_frame>Baseline, Week 24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baseline and Change From Baseline at Week 24 in Fasting Plasma Glucose (FPG) - Open Label Cohort</measure>
    <time_frame>Baseline, Week 24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Achieving Therapeutic Glycemic Response (A1C &lt; 7.0%) at Week 24 - Open Label Cohort</measure>
    <time_frame>Week 24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baseline and Change From Baseline at Week 24 in Postprandial Glucose (PPG) Area Under the Curve (AUC) - Open Label Cohort</measure>
    <time_frame>Baseline, Week 24</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Baseline Demographic Characteristic (Age, Continuous) - Summary for ST + LT Treatment Period - Open-Label Cohort</measure>
    <time_frame>Baseline</time_frame>
    <description>This cohort represents a different population (screening A1C &gt; 10.0% and ≤ 12.0%) than the double-blind cohort, and was presented separately in the study report.</description>
  </other_outcome>
  <other_outcome>
    <measure>Baseline Demographic Characteristics - Summary for ST + LT Treatment Period - Open-Label Cohort</measure>
    <time_frame>Baseline</time_frame>
    <description>This cohort represents a different population (screening A1C &gt; 10.0% and ≤ 12.0%) than the double-blind cohort, and was presented separately in the study report.</description>
  </other_outcome>
  <other_outcome>
    <measure>Baseline Demographic Characteristic (Weight) - Summary for ST + LT Treatment Period - Open-Label Cohort</measure>
    <time_frame>Baseline</time_frame>
    <description>This cohort represents a different population (screening A1C &gt; 10.0% and ≤ 12.0%) than the double-blind cohort, and was presented separately in the study report.</description>
  </other_outcome>
  <other_outcome>
    <measure>Baseline Demographic Characteristic (Body Mass Index) - Summary for ST + LT Treatment Period - Open-Label Cohort</measure>
    <time_frame>Baseline</time_frame>
    <description>This cohort represents a different population (screening A1C &gt; 10.0% and ≤ 12.0%) than the double-blind cohort, and was presented separately in the study report.</description>
  </other_outcome>
  <other_outcome>
    <measure>Overall Summary of Adverse Events During ST+LT Treatment Period</measure>
    <time_frame>AEs: up to last treatment day + 1 day or last visit; SAEs: up to last treatment day + 30 days or last visit + 30 days. Mean duration of exposure was 109 weeks in 10 mg arm, 94.7 weeks in 2.5 mg arm, 103 weeks in 5 mg arm, and 98.4 weeks in placebo arm.</time_frame>
    <description>AE=any new untoward medical occurrence or worsening of a pre-existing medical condition which does not necessarily have a causal relationship with this treatment. SAE=any untoward medical occurrence that at any dose: results in death, is life-threatening, requires inpatient hospitalization or causes prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect, results in development of drug dependency or drug abuse, is an important medical event. Related events=relationship of certain, probable, possible, or missing.</description>
  </other_outcome>
  <other_outcome>
    <measure>Marked Laboratory Abnormalities - During ST + LT Treatment Period</measure>
    <time_frame>Lab assessments taken during and up to 14 days after the last dose of study drug during the ST + LT Treatment Period. Mean duration of exposure was 109 weeks in 10 mg arm, 94.7 weeks in 2.5 mg arm, 103 weeks in 5 mg arm, and 98.4 weeks in placebo arm.</time_frame>
    <description>A laboratory value was considered a marked abnormality if it is outside the pre-defined criteria for marked abnormality and the on-treatment value was more extreme (farther from the limit) than the baseline value. Pre-Rx=pretreatment; ULN=upper limit of normal; ALP=alkaline phosphatase; AST=aspartate aminotransferase; ALT=alanine aminotransferase; unspec=unspecified; sodium serum low: &lt;0.9 x Pre-Rx &amp; &lt;=130mEq/L / high: &gt;1.1 x Pre-Rx &amp; &gt;=150mEq/L; potassium, serum low: &lt;=0.8 x Pre-Rx &amp; &gt;=6.0mEq/L / high: 1.2 x Pre-Rx &amp; &gt;=6.0mEq/L; LLN=lower limit of normal.</description>
  </other_outcome>
  <other_outcome>
    <measure>Baseline and Changes From Baseline in Hemoglobin During the ST + LT Period</measure>
    <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Baseline and Changes From Baseline in Hematocrit During the ST + LT Period</measure>
    <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Baseline and Changes From Baseline in Red Blood Cell Counts (x 10^6 c/µL) During the ST + LT Period</measure>
    <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Baseline and Changes From Baseline in Platelet Counts (x 10^9 c/L) During the ST + LT Period</measure>
    <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Baseline and Changes From Baseline in White Blood Cell Counts (x 10^3 c/µL) During the ST + LT Period</measure>
    <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Baseline and Changes From Baseline in Absolute Neutrophil Counts (x 10^3 c/µL) During the ST + LT Period</measure>
    <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Baseline and Changes From Baseline in Absolute Lymphocyte Counts (x 10^3 c/µL) During the ST + LT Period</measure>
    <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Baseline and Changes From Baseline in Absolute Monocyte Counts (x 10^3 c/µL) During the ST + LT Period</measure>
    <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Baseline and Changes From Baseline in Absolute Basophil Counts (x 10^3 c/µL) During the ST + LT Period</measure>
    <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Baseline and Changes From Baseline in Absolute Eosinophil Counts (x 10^3 c/µL) During the ST + LT Period</measure>
    <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Changes From Baseline in Systolic Blood Pressure During the ST + LT Period</measure>
    <time_frame>Baseline, Weeks 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Changes From Baseline in Diastolic Blood Pressure During the ST + LT Period</measure>
    <time_frame>Baseline, Weeks 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Changes From Baseline in Heart Rate During the ST + LT Period</measure>
    <time_frame>Baseline, Weeks 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Electrocardiogram (ECG) Tracings - Shift Table From Baseline (BL) to Selected Visits During ST + LT Treatment Period</measure>
    <time_frame>Baseline, Weeks 12, 24, 76, 102, 154, 206</time_frame>
    <description>The normality/abnormality of the ECG tracing was determined by the investigator.</description>
  </other_outcome>
  <other_outcome>
    <measure>Overall Summary of Adverse Events During ST+LT Treatment Period - Open-Label Cohort</measure>
    <time_frame>AEs: up to last treatment day + 1 day or last visit; SAEs: up to last treatment day + 30 days or last visit + 30 days. Mean duration of exposure was 34 weeks.</time_frame>
    <description>AE=any new untoward medical occurrence or worsening of a pre-existing medical condition which does not necessarily have a causal relationship with this treatment. SAE=any untoward medical occurrence that at any dose: results in death, is life-threatening, requires inpatient hospitalization or causes prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect, results in development of drug dependency or drug abuse, is an important medical event. Related events=relationship of certain, probable, possible, or missing.</description>
  </other_outcome>
  <other_outcome>
    <measure>Marked Laboratory Abnormalities During ST + LT Treatment Period - Open-Label Cohort</measure>
    <time_frame>Lab assessments taken during and up to 14 days after the last dose of study drug during the ST + LT Treatment Period. Mean duration of exposure was 34 weeks.</time_frame>
    <description>A laboratory value was considered a marked abnormality if it is outside the pre-defined criteria for marked abnormality and the on-treatment value was more extreme (farther from the limit) than the baseline value. Pre-Rx=pretreatment; ULN=upper limit of normal; ALP=alkaline phosphatase; AST=aspartate aminotransferase; ALT=alanine aminotransferase; unspec=unspecified; sodium serum low: &lt;0.9 x Pre-Rx &amp; &lt;=130mEq/L / high: &gt;1.1 x Pre-Rx &amp; &gt;=150mEq/L; potassium, serum low: &lt;=0.8 x Pre-Rx &amp; &gt;=6.0mEq/L / high: 1.2 x Pre-Rx &amp; &gt;=6.0mEq/L; LLN=lower limit of normal.</description>
  </other_outcome>
  <other_outcome>
    <measure>All Reported Hypoglycemic Adverse Events During ST + LT Treatment Period</measure>
    <time_frame>AEs: up to last treatment day + 1 day or last visit; SAEs: up to last treatment day + 30 days or last visit + 30 days. Mean duration of exposure was 109 weeks in 10 mg arm, 94.7 weeks in 2.5 mg arm, 103 weeks in 5 mg arm, and 98.4 weeks in placebo arm.</time_frame>
    <description>Hypoglycemic Events are based upon the Saxagliptin Predefined List of Events, which included hypoglycemia, blood glucose decreased, and hypoglycemic unconsciousness.</description>
  </other_outcome>
  <other_outcome>
    <measure>Confirmed Hypoglycemia During ST + LT Treatment Period</measure>
    <time_frame>AEs: up to last treatment day + 1 day or last visit; SAEs: up to last treatment day + 30 days or last visit + 30 days. Mean duration of exposure was 109 weeks in 10 mg arm, 94.7 weeks in 2.5 mg arm, 103 weeks in 5 mg arm, and 98.4 weeks in placebo arm.</time_frame>
    <description>'Confirmed' = recorded on the hypoglycemia AE case report form page with a fingerstick glucose &lt;= 50 mg/dL and associated symptoms</description>
  </other_outcome>
  <other_outcome>
    <measure>All Reported Hypoglycemic Adverse Events During ST + LT Treatment Period - Open-Label Cohort</measure>
    <time_frame>AEs: up to last treatment day + 1 day or last visit; SAEs: up to last treatment day + 30 days or last visit + 30 days. Mean duration of exposure was 34 weeks.</time_frame>
    <description>Hypoglycemic Events are based upon the Saxagliptin Predefined List of Events, which included hypoglycemia, blood glucose decreased, and hypoglycemic unconsciousness.</description>
  </other_outcome>
  <other_outcome>
    <measure>Confirmed Hypoglycemia During ST + LT Treatment Period - Open-Label Cohort</measure>
    <time_frame>AEs: up to last treatment day + 1 day or last visit; SAEs: up to last treatment day + 30 days or last visit + 30 days. Mean duration of exposure was 34 weeks.</time_frame>
    <description>'Confirmed' = recorded on the hypoglycemia AE case report form page with a fingerstick glucose &lt;= 50 mg/dL and associated symptoms</description>
  </other_outcome>
  <other_outcome>
    <measure>Electrocardiogram (ECG) Tracings - Shift Table From Baseline (BL) to Selected Visits During ST + LT Treatment Period - Open Label Cohort</measure>
    <time_frame>Baseline, Weeks 12, 24, 76, 102, 154, 206</time_frame>
    <description>The normality/abnormality of the ECG tracing was determined by the investigator.</description>
  </other_outcome>
  <other_outcome>
    <measure>Changes From Baseline in Systolic Blood Pressure During the ST + LT Period - Open Label Cohort</measure>
    <time_frame>Baseline, Weeks 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Changes From Baseline in Diastolic Blood Pressure During the ST + LT Period - Open Label Cohort</measure>
    <time_frame>Baseline, Weeks 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Changes From Baseline in Heart Rate During the ST + LT Period - Open Label Cohort</measure>
    <time_frame>Baseline, Weeks 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167</time_frame>
  </other_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">1035</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>Saxagliptin 2.5 mg (A)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Metformin 500-2000 mg (as needed for rescue)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saxagliptin 5 mg (B)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Metformin 500-2000 mg (as needed for rescue)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saxagliptin 10 mg (C)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Metformin 500-2000 mg (as needed for rescue)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo (D)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Metformin 500-2000 mg (as needed for rescue)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Open-Label Treatment Cohort (Direct Enrollees) (E)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Saxagliptin 10 mg
Metformin 500-2000 mg (as needed for rescue)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saxagliptin</intervention_name>
    <description>Tablets, Oral, 2.5 mg, Once daily (24 weeks short term [ST], 42 months long term [LT])</description>
    <arm_group_label>Saxagliptin 2.5 mg (A)</arm_group_label>
    <other_name>BMS-477118</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saxagliptin</intervention_name>
    <description>Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT)</description>
    <arm_group_label>Saxagliptin 5 mg (B)</arm_group_label>
    <other_name>BMS-477118</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saxagliptin</intervention_name>
    <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT)</description>
    <arm_group_label>Saxagliptin 10 mg (C)</arm_group_label>
    <other_name>BMS-477118</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo matching Saxagliptin</intervention_name>
    <description>Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT)</description>
    <arm_group_label>Placebo (D)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metformin</intervention_name>
    <description>Tablets, Oral, 500 mg, daily (42 months LT)</description>
    <arm_group_label>Placebo (D)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo matching Metformin</intervention_name>
    <description>Tablets, Oral, 0 mg, daily (42 months LT)</description>
    <arm_group_label>Saxagliptin 2.5 mg (A)</arm_group_label>
    <arm_group_label>Saxagliptin 5 mg (B)</arm_group_label>
    <arm_group_label>Saxagliptin 10 mg (C)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saxagliptin</intervention_name>
    <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT) Open Label</description>
    <arm_group_label>Open-Label Treatment Cohort (Direct Enrollees) (E)</arm_group_label>
    <other_name>BMS-477118</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metformin</intervention_name>
    <description>Tablets, Oral, 500-2000 mg (as needed for rescue)</description>
    <arm_group_label>Saxagliptin 2.5 mg (A)</arm_group_label>
    <arm_group_label>Saxagliptin 5 mg (B)</arm_group_label>
    <arm_group_label>Saxagliptin 10 mg (C)</arm_group_label>
    <arm_group_label>Placebo (D)</arm_group_label>
    <arm_group_label>Open-Label Treatment Cohort (Direct Enrollees) (E)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 2 diabetes mellitus

          -  Drug naive

          -  Hemoglobin (Hb) A1c &gt;= 7.0% and &lt;= 10.0% (&gt;10% and &lt;= 12% for open label arm)

          -  Fasting C-peptide &gt;= 1 ng/mL

          -  Body mass index &lt;= 40 kg/m2

        Exclusion Criteria:

          -  Symptomatic poorly controlled diabetes

          -  Recent cardiac or cerebrovascular event

          -  Serum creatinine &gt;= 1.5 mg/dL for males and &gt;= 1.4 mg/dL for Women of Child Bearing
             Potential
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>77 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Anniston</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Calera</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Jonesboro</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Mesa</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Pheonix</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Anaheim</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Fountain Valley</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Fresno</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Northridge</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Rolling Hills Estates</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Santa Ana</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Spring Valley</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Tustin</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Castle Rock</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Loveland</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Altamonte Springs</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Chipley</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Cocoa Beach</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Coral Gables</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Fort Lauderdale</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Jupiter</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Kissimmee</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Marianna</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>New Port Richey</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Ocala</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>West Palm Beach</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Vernon Hills</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Dubuque</city>
        <state>Iowa</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Waterloo</city>
        <state>Iowa</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Munfordville</city>
        <state>Kentucky</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>West Monroe</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Chester</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Prince Frederick</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Ayer</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Rolling Fork</city>
        <state>Mississippi</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Springfield</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Kalispell</city>
        <state>Montana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Middletown</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Toms River</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Cooperstown</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Huntersville</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Sparta</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Statesville</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Winston Salem</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Athens</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Franklin</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Fleetwood</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Bristol</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Morristown</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Bryan</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Temple</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Texarkana</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>The Colony</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Virginia Beach</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Olympia</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Woollongong</city>
        <state>New South Wales</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Brisbane</city>
        <state>Queensland</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Kippa Ring</city>
        <state>Queensland</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Meadowbrook</city>
        <state>Queensland</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Adelaide</city>
        <state>South Australia</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Woodville South</city>
        <state>South Australia</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Perth</city>
        <state>Western Australia</state>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Kelowna</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Quesnel</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Portage La Prairie</city>
        <state>Manitoba</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Bathurst</city>
        <state>New Brunswick</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Moncton</city>
        <state>New Brunswick</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Manuels</city>
        <state>Newfoundland and Labrador</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Mount Pearl</city>
        <state>Newfoundland and Labrador</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>St. John's</city>
        <state>Newfoundland and Labrador</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Newmarket</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Oakville</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Peterborough</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Sarnia</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Strathroy</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Thornhill</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Charlottetown</city>
        <state>Prince Edward Island</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Drummondville</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Fleurimont</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Gatineau</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Granby</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Longueuil</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>St. Leonard</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Ste-Foy</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Saskatoon</city>
        <state>Saskatchewan</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Mexico City</city>
        <state>Distrito Federal</state>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Mexico D.F.</city>
        <state>Distrito Federal</state>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Guadalajara</city>
        <state>Jalisco</state>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Monterrey</city>
        <state>Nuevo Leon</state>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Hermosillo</city>
        <state>Sonora</state>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Aguascalientes</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Durango</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Carolina</city>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Guaynabo</city>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Ponce</city>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Rio Piedras</city>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>San Juan</city>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Hualien</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Taichung</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Local Institution</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Canada</country>
    <country>Mexico</country>
    <country>Puerto Rico</country>
    <country>Taiwan</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.fda.gov/MEDWATCH/safety.htm</url>
    <description>For FDA Safety Alerts and Recalls refer to the following link www.fda.gov/MEDWATCH/safety.htm</description>
  </link>
  <reference>
    <citation>Rosenstock J, Aguilar-Salinas C, Klein E, Nepal S, List J, Chen R; CV181-011 Study Investigators. Effect of saxagliptin monotherapy in treatment-naïve patients with type 2 diabetes. Curr Med Res Opin. 2009 Oct;25(10):2401-11. doi: 10.1185/03007990903178735.</citation>
    <PMID>19650754</PMID>
  </reference>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 15, 2005</study_first_submitted>
  <study_first_submitted_qc>July 15, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 21, 2005</study_first_posted>
  <results_first_submitted>April 12, 2011</results_first_submitted>
  <results_first_submitted_qc>April 12, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 11, 2011</results_first_posted>
  <disposition_first_submitted>July 30, 2009</disposition_first_submitted>
  <disposition_first_submitted_qc>November 12, 2009</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">March 4, 2010</disposition_first_posted>
  <last_update_submitted>March 16, 2015</last_update_submitted>
  <last_update_submitted_qc>March 16, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 3, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Saxagliptin</mesh_term>
    <mesh_term>Metformin</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>1035 subjects were enrolled; 422 entered the 2-week dietary/exercise placebo lead-in. 21 did not enter double-blind treatment period (19 discontinued, 2 randomized but did not receive study drug). 68 with screening hemoglobin A1c (A1C) &gt;10.0% and ≤12.0% entered directly in the open-label cohort; 66 received at least 1 dose of saxagliptin 10mg.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Saxagliptin 2.5 mg</title>
          <description>Tablets, Oral, 2.5 mg, Once daily (24 weeks short term [ST], 42 months long term [LT]); Metformin 500-2000 mg (as needed for rescue).</description>
        </group>
        <group group_id="P2">
          <title>Saxagliptin 5 mg</title>
          <description>Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
        </group>
        <group group_id="P3">
          <title>Saxagliptin 10 mg</title>
          <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
        </group>
        <group group_id="P4">
          <title>Placebo</title>
          <description>Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)</description>
        </group>
        <group group_id="P5">
          <title>Open-Label Treatment Cohort (Direct Enrollees)</title>
          <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>24-week Short-term Treatment Period</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="102"/>
                <participants group_id="P2" count="106"/>
                <participants group_id="P3" count="98"/>
                <participants group_id="P4" count="95"/>
                <participants group_id="P5" count="66"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="73"/>
                <participants group_id="P2" count="68"/>
                <participants group_id="P3" count="69"/>
                <participants group_id="P4" count="55"/>
                <participants group_id="P5" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="29"/>
                <participants group_id="P2" count="38"/>
                <participants group_id="P3" count="29"/>
                <participants group_id="P4" count="40"/>
                <participants group_id="P5" count="41"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lack of Efficacy</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="21"/>
                <participants group_id="P3" count="14"/>
                <participants group_id="P4" count="25"/>
                <participants group_id="P5" count="30"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Subject Withdrew Consent</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="11"/>
                <participants group_id="P3" count="5"/>
                <participants group_id="P4" count="10"/>
                <participants group_id="P5" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="4"/>
                <participants group_id="P5" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Poor / Non-compliance</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Subject No Longer Meets Study Criteria</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other Reason</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>48-month Short Term + Long Term Period</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="102"/>
                <participants group_id="P2" count="106"/>
                <participants group_id="P3" count="98"/>
                <participants group_id="P4" count="95"/>
                <participants group_id="P5" count="66"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="24"/>
                <participants group_id="P3" count="28"/>
                <participants group_id="P4" count="24"/>
                <participants group_id="P5" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="79"/>
                <participants group_id="P2" count="82"/>
                <participants group_id="P3" count="70"/>
                <participants group_id="P4" count="71"/>
                <participants group_id="P5" count="58"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lack of Efficacy</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="27"/>
                <participants group_id="P3" count="21"/>
                <participants group_id="P4" count="26"/>
                <participants group_id="P5" count="25"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Subject Withdrew Consent</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="28"/>
                <participants group_id="P3" count="17"/>
                <participants group_id="P4" count="24"/>
                <participants group_id="P5" count="10"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="10"/>
                <participants group_id="P4" count="5"/>
                <participants group_id="P5" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="7"/>
                <participants group_id="P3" count="12"/>
                <participants group_id="P4" count="11"/>
                <participants group_id="P5" count="12"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Poor / Non-compliance</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Subject No Longer Meets Study Criteria</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Pregnancy</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Administrative Reason by Sponsor</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Missing</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other Reason</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Saxagliptin 2.5 mg</title>
          <description>Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
        </group>
        <group group_id="B2">
          <title>Saxagliptin 5 mg</title>
          <description>Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
        </group>
        <group group_id="B3">
          <title>Saxagliptin 10 mg</title>
          <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
        </group>
        <group group_id="B4">
          <title>Placebo</title>
          <description>Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="102"/>
            <count group_id="B2" value="106"/>
            <count group_id="B3" value="98"/>
            <count group_id="B4" value="95"/>
            <count group_id="B5" value="401"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53.27" spread="10.06"/>
                    <measurement group_id="B2" value="53.91" spread="11.57"/>
                    <measurement group_id="B3" value="52.73" spread="11.27"/>
                    <measurement group_id="B4" value="53.91" spread="12.32"/>
                    <measurement group_id="B5" value="53.46" spread="11.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="91"/>
                    <measurement group_id="B2" value="86"/>
                    <measurement group_id="B3" value="84"/>
                    <measurement group_id="B4" value="77"/>
                    <measurement group_id="B5" value="338"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;= 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="14"/>
                    <measurement group_id="B4" value="18"/>
                    <measurement group_id="B5" value="63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=75 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                    <measurement group_id="B2" value="52"/>
                    <measurement group_id="B3" value="53"/>
                    <measurement group_id="B4" value="48"/>
                    <measurement group_id="B5" value="197"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="58"/>
                    <measurement group_id="B2" value="54"/>
                    <measurement group_id="B3" value="45"/>
                    <measurement group_id="B4" value="47"/>
                    <measurement group_id="B5" value="204"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="89"/>
                    <measurement group_id="B2" value="93"/>
                    <measurement group_id="B3" value="80"/>
                    <measurement group_id="B4" value="79"/>
                    <measurement group_id="B5" value="341"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black/African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="6"/>
                    <measurement group_id="B5" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="7"/>
                    <measurement group_id="B5" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Partcipants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hispanic / Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="14"/>
                    <measurement group_id="B4" value="15"/>
                    <measurement group_id="B5" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Hispanic / Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                    <measurement group_id="B2" value="49"/>
                    <measurement group_id="B3" value="42"/>
                    <measurement group_id="B4" value="38"/>
                    <measurement group_id="B5" value="174"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="41"/>
                    <measurement group_id="B2" value="43"/>
                    <measurement group_id="B3" value="42"/>
                    <measurement group_id="B4" value="42"/>
                    <measurement group_id="B5" value="168"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age Categorization, Female Only</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>=&lt; 50 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="22"/>
                    <measurement group_id="B4" value="19"/>
                    <measurement group_id="B5" value="82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt; 50 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="31"/>
                    <measurement group_id="B4" value="29"/>
                    <measurement group_id="B5" value="115"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="92.10" spread="18.39"/>
                    <measurement group_id="B2" value="91.09" spread="18.53"/>
                    <measurement group_id="B3" value="89.30" spread="17.67"/>
                    <measurement group_id="B4" value="86.56" spread="16.90"/>
                    <measurement group_id="B5" value="89.84" spread="17.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31.90" spread="4.82"/>
                    <measurement group_id="B2" value="32.30" spread="4.53"/>
                    <measurement group_id="B3" value="31.71" spread="4.71"/>
                    <measurement group_id="B4" value="30.93" spread="4.26"/>
                    <measurement group_id="B5" value="31.73" spread="4.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index Categorization</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt; 30</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="40"/>
                    <measurement group_id="B3" value="35"/>
                    <measurement group_id="B4" value="42"/>
                    <measurement group_id="B5" value="153"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;= 30</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66"/>
                    <measurement group_id="B2" value="66"/>
                    <measurement group_id="B3" value="63"/>
                    <measurement group_id="B4" value="53"/>
                    <measurement group_id="B5" value="248"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Hemoglobin A1c (A1C) Changes From Baseline at Week 24</title>
        <description>To compare the change from baseline in HbA1c achieved with each dose of saxagliptin versus placebo in treatment naive subjects with type 2 diabetes who have inadequate glycemic control defined as A1C ≥7.0% and ≤10.0%.</description>
        <time_frame>Baseline, Week 24</time_frame>
        <population>Randomized participants with both a baseline and post-baseline value (up to Week 24).</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg</title>
            <description>Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg</title>
            <description>Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
            <description>Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)</description>
          </group>
        </group_list>
        <measure>
          <title>Hemoglobin A1c (A1C) Changes From Baseline at Week 24</title>
          <description>To compare the change from baseline in HbA1c achieved with each dose of saxagliptin versus placebo in treatment naive subjects with type 2 diabetes who have inadequate glycemic control defined as A1C ≥7.0% and ≤10.0%.</description>
          <population>Randomized participants with both a baseline and post-baseline value (up to Week 24).</population>
          <units>Percentage of glycosylated hemoglobins</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="102"/>
                <count group_id="O2" value="106"/>
                <count group_id="O3" value="98"/>
                <count group_id="O4" value="95"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline Mean</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.91" spread="0.09"/>
                    <measurement group_id="O2" value="7.98" spread="0.11"/>
                    <measurement group_id="O3" value="7.85" spread="0.09"/>
                    <measurement group_id="O4" value="7.88" spread="0.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Adjusted Mean Change from Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.43" spread="0.10"/>
                    <measurement group_id="O2" value="-0.46" spread="0.10"/>
                    <measurement group_id="O3" value="-0.54" spread="0.10"/>
                    <measurement group_id="O4" value="0.19" spread="0.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <p_value_desc>Between-group comparisons significant at alpha = 0.019, significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Adjusted mean difference for saxagliptin groups vs placebo in Week 24 (LOCF). Adjusted for baseline.</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.62</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.14</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.90</ci_lower_limit>
            <ci_upper_limit>-0.33</ci_upper_limit>
            <estimate_desc>ANCOVA model:post - pre = pre treatment</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <p_value_desc>Between-group comparisons significant at alpha = 0.019, significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Adjusted mean difference for saxagliptin groups vs placebo in Week 24 (LOCF). Adjusted for baseline.</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.64</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.14</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.93</ci_lower_limit>
            <ci_upper_limit>-0.36</ci_upper_limit>
            <estimate_desc>ANCOVA model:post - pre = pre treatment</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <p_value_desc>Between-group comparisons significant at alpha = 0.019, significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Adjusted mean difference for saxagliptin groups vs placebo in Week 24 (LOCF). Adjusted for baseline.</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.73</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.15</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.02</ci_lower_limit>
            <ci_upper_limit>-0.44</ci_upper_limit>
            <estimate_desc>ANCOVA model:post - pre = pre treatment</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Baseline and Change From Baseline at Week 24 in Fasting Plasma Glucose (FPG)</title>
        <time_frame>Baseline, Week 24</time_frame>
        <population>Randomized participants with measure at given time points, Last Observation Carried Forward (LOCF).</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg</title>
            <description>Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg</title>
            <description>Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
            <description>Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline and Change From Baseline at Week 24 in Fasting Plasma Glucose (FPG)</title>
          <population>Randomized participants with measure at given time points, Last Observation Carried Forward (LOCF).</population>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="101"/>
                <count group_id="O2" value="105"/>
                <count group_id="O3" value="97"/>
                <count group_id="O4" value="92"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="177.72" spread="4.12"/>
                    <measurement group_id="O2" value="171.31" spread="4.09"/>
                    <measurement group_id="O3" value="176.51" spread="4.43"/>
                    <measurement group_id="O4" value="171.85" spread="4.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Adjusted Change from Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-14.53" spread="3.82"/>
                    <measurement group_id="O2" value="-8.67" spread="3.74"/>
                    <measurement group_id="O3" value="-16.75" spread="3.89"/>
                    <measurement group_id="O4" value="6.06" spread="4.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0002</p_value>
            <p_value_desc>Significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Adjusted mean difference for saxagliptin groups vs placebo in Week 24 (LOCF). Adjusted for baseline.</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-20.60</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>5.53</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-31.47</ci_lower_limit>
            <ci_upper_limit>-9.72</ci_upper_limit>
            <estimate_desc>ANCOVA model:post - pre = pre treatment</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0074</p_value>
            <p_value_desc>Significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Adjusted mean difference for saxagliptin groups vs placebo in Week 24 (LOCF). Adjusted for baseline.</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-14.73</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>5.48</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-25.50</ci_lower_limit>
            <ci_upper_limit>-3.97</ci_upper_limit>
            <estimate_desc>ANCOVA model:post - pre = pre treatment</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <p_value_desc>Significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Adjusted mean difference for saxagliptin groups vs placebo in Week 24 (LOCF). Adjusted for baseline.</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-22.81</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>5.58</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-33.79</ci_lower_limit>
            <ci_upper_limit>-11.84</ci_upper_limit>
            <estimate_desc>ANCOVA model:post - pre = pre treatment</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants Achieving Therapeutic Glycemic Response (A1C &lt; 7.0%) at Week 24</title>
        <time_frame>Week 24</time_frame>
        <population>Randomized Participants with measurement at time point, Last Observation Carried Forward (LOCF)</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg</title>
            <description>Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg</title>
            <description>Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
            <description>Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Achieving Therapeutic Glycemic Response (A1C &lt; 7.0%) at Week 24</title>
          <population>Randomized Participants with measurement at time point, Last Observation Carried Forward (LOCF)</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
                <count group_id="O2" value="103"/>
                <count group_id="O3" value="95"/>
                <count group_id="O4" value="92"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.0"/>
                    <measurement group_id="O2" value="37.9"/>
                    <measurement group_id="O3" value="41.1"/>
                    <measurement group_id="O4" value="23.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.1141</p_value>
            <p_value_desc>Significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.</p_value_desc>
            <method>Fisher Exact</method>
            <method_desc>The exact 95% CIs is based on the standardized statistic and inverting the one 2-sided test.</method_desc>
            <param_type>Difference in Proportions</param_type>
            <param_value>11.1</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-3.1</ci_lower_limit>
            <ci_upper_limit>24.9</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0443</p_value>
            <p_value_desc>Significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.</p_value_desc>
            <method>Fisher Exact</method>
            <method_desc>The exact 95% CIs is based on the standardized statistic and inverting the one 2-sided test.</method_desc>
            <param_type>Difference in Proportions</param_type>
            <param_value>14.0</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.1</ci_lower_limit>
            <ci_upper_limit>27.6</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0133</p_value>
            <p_value_desc>Significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.</p_value_desc>
            <method>Fisher Exact</method>
            <method_desc>The exact 95% CIs is based on the standardized statistic and inverting the one 2-sided test.</method_desc>
            <param_type>Difference in Proportions</param_type>
            <param_value>17.1</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.8</ci_lower_limit>
            <ci_upper_limit>31.0</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Baseline and Change From Baseline at Week 24 in Postprandial Glucose (PPG) Area Under the Curve (AUC)</title>
        <time_frame>Baseline, Week 24</time_frame>
        <population>Randomized participants with measure at given time points, Last Observation Carried Forward (LOCF).</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg</title>
            <description>Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg</title>
            <description>Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
            <description>Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline and Change From Baseline at Week 24 in Postprandial Glucose (PPG) Area Under the Curve (AUC)</title>
          <population>Randomized participants with measure at given time points, Last Observation Carried Forward (LOCF).</population>
          <units>mg*min/dL</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="74"/>
                <count group_id="O2" value="79"/>
                <count group_id="O3" value="73"/>
                <count group_id="O4" value="66"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45030" spread="1368.1"/>
                    <measurement group_id="O2" value="45691" spread="1209.8"/>
                    <measurement group_id="O3" value="44614" spread="1394.0"/>
                    <measurement group_id="O4" value="46030" spread="1397.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Adjusted Change from Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6868" spread="1167.7"/>
                    <measurement group_id="O2" value="-6896" spread="1130.2"/>
                    <measurement group_id="O3" value="-8084" spread="1176.2"/>
                    <measurement group_id="O4" value="-646.6" spread="1236.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0003</p_value>
            <p_value_desc>Significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Adjusted mean difference for saxagliptin groups vs placebo in Week 24 (LOCF). Adjusted for baseline.</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-6221</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>1701.3</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-9570</ci_lower_limit>
            <ci_upper_limit>-2872</ci_upper_limit>
            <estimate_desc>ANCOVA model:post - pre = pre treatment</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0002</p_value>
            <p_value_desc>Significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Adjusted mean difference for saxagliptin groups vs placebo in Week 24 (LOCF). Adjusted for baseline.</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-6249</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>1675.1</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-9546</ci_lower_limit>
            <ci_upper_limit>-2952</ci_upper_limit>
            <estimate_desc>ANCOVA model:post - pre = pre treatment</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <p_value_desc>Significance testing based on hierarchical testing. Primary and secondary endpoints are presented in order of testing.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Adjusted mean difference for saxagliptin groups vs placebo in Week 24 (LOCF). Adjusted for baseline.</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-7437</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>1707.6</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-10798</ci_lower_limit>
            <ci_upper_limit>-4076</ci_upper_limit>
            <estimate_desc>ANCOVA model:post - pre = pre treatment</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Baseline and Change From Baseline at Week 24 in Fasting Plasma Glucose (FPG) - Open Label Cohort</title>
        <time_frame>Baseline, Week 24</time_frame>
        <population>Open Label Subjects with Measurement at Timepoint; Last Observation Carried Forward (LOCF)</population>
        <group_list>
          <group group_id="O1">
            <title>Open-Label Cohort (Direct Enrollees)</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline and Change From Baseline at Week 24 in Fasting Plasma Glucose (FPG) - Open Label Cohort</title>
          <population>Open Label Subjects with Measurement at Timepoint; Last Observation Carried Forward (LOCF)</population>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="64"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="241.08" spread="6.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-33.42" spread="5.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants Achieving Therapeutic Glycemic Response (A1C &lt; 7.0%) at Week 24 - Open Label Cohort</title>
        <time_frame>Week 24</time_frame>
        <population>Open Label Participants with measurement at time point, Last Observation Carried Forward (LOCF)</population>
        <group_list>
          <group group_id="O1">
            <title>Open Label Cohort (Direct Enrollees)</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Achieving Therapeutic Glycemic Response (A1C &lt; 7.0%) at Week 24 - Open Label Cohort</title>
          <population>Open Label Participants with measurement at time point, Last Observation Carried Forward (LOCF)</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="64"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>A1C Changes From Baseline at Week 24 - Open Label Cohort</title>
        <description>To compare the change from baseline in HbA1c achieved with each dose of saxagliptin versus placebo in treatment naive subjects with type 2 diabetes who have inadequate glycemic control defined as A1C ≥7.0% and ≤10.0%.</description>
        <time_frame>Baseline, Week 24</time_frame>
        <population>Open-label participants with both a baseline and a post-baseline (up to Week 24)</population>
        <group_list>
          <group group_id="O1">
            <title>Open Label Cohort (Direct Enrollees)</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>A1C Changes From Baseline at Week 24 - Open Label Cohort</title>
          <description>To compare the change from baseline in HbA1c achieved with each dose of saxagliptin versus placebo in treatment naive subjects with type 2 diabetes who have inadequate glycemic control defined as A1C ≥7.0% and ≤10.0%.</description>
          <population>Open-label participants with both a baseline and a post-baseline (up to Week 24)</population>
          <units>Percentage of glycosylated hemoglobins</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="64"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline Mean</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.70" spread="0.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mean Change from Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.87" spread="0.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Baseline and Change From Baseline at Week 24 in Postprandial Glucose (PPG) Area Under the Curve (AUC) - Open Label Cohort</title>
        <time_frame>Baseline, Week 24</time_frame>
        <population>Open Label participants with measure at given time points, Last Observation Carried Forward (LOCF).</population>
        <group_list>
          <group group_id="O1">
            <title>Open Label Cohort (Direct Enrollees)</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline and Change From Baseline at Week 24 in Postprandial Glucose (PPG) Area Under the Curve (AUC) - Open Label Cohort</title>
          <population>Open Label participants with measure at given time points, Last Observation Carried Forward (LOCF).</population>
          <units>mg*min/dL</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="64"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60687" spread="2312.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-11078" spread="2132.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Baseline Demographic Characteristic (Age, Continuous) - Summary for ST + LT Treatment Period - Open-Label Cohort</title>
        <description>This cohort represents a different population (screening A1C &gt; 10.0% and ≤ 12.0%) than the double-blind cohort, and was presented separately in the study report.</description>
        <time_frame>Baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Open-Label Treatment Cohort (Direct Enrollees)</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline Demographic Characteristic (Age, Continuous) - Summary for ST + LT Treatment Period - Open-Label Cohort</title>
          <description>This cohort represents a different population (screening A1C &gt; 10.0% and ≤ 12.0%) than the double-blind cohort, and was presented separately in the study report.</description>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49.09" spread="8.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Baseline Demographic Characteristics - Summary for ST + LT Treatment Period - Open-Label Cohort</title>
        <description>This cohort represents a different population (screening A1C &gt; 10.0% and ≤ 12.0%) than the double-blind cohort, and was presented separately in the study report.</description>
        <time_frame>Baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Open-Label Treatment Cohort (Direct Enrollees)</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline Demographic Characteristics - Summary for ST + LT Treatment Period - Open-Label Cohort</title>
          <description>This cohort represents a different population (screening A1C &gt; 10.0% and ≤ 12.0%) than the double-blind cohort, and was presented separately in the study report.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Age &lt;65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Age &gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Age &gt;=75 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Gender, Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Gender, Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Age =&lt;50 years, females only</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Age &gt;50 years, females only</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Race, White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Race, Black/African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Race, Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Race, Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ethnicity, Hispanic/Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ethnicity, Not Hispanic/Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ethnicity, Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Body Mass Index &lt;30%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Body Mass Index &gt;=30%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Baseline Demographic Characteristic (Weight) - Summary for ST + LT Treatment Period - Open-Label Cohort</title>
        <description>This cohort represents a different population (screening A1C &gt; 10.0% and ≤ 12.0%) than the double-blind cohort, and was presented separately in the study report.</description>
        <time_frame>Baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Open-Label Treatment Cohort (Direct Enrollees)</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline Demographic Characteristic (Weight) - Summary for ST + LT Treatment Period - Open-Label Cohort</title>
          <description>This cohort represents a different population (screening A1C &gt; 10.0% and ≤ 12.0%) than the double-blind cohort, and was presented separately in the study report.</description>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.41" spread="20.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Baseline Demographic Characteristic (Body Mass Index) - Summary for ST + LT Treatment Period - Open-Label Cohort</title>
        <description>This cohort represents a different population (screening A1C &gt; 10.0% and ≤ 12.0%) than the double-blind cohort, and was presented separately in the study report.</description>
        <time_frame>Baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Open-Label Treatment Cohort (Direct Enrollees)</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline Demographic Characteristic (Body Mass Index) - Summary for ST + LT Treatment Period - Open-Label Cohort</title>
          <description>This cohort represents a different population (screening A1C &gt; 10.0% and ≤ 12.0%) than the double-blind cohort, and was presented separately in the study report.</description>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.73" spread="4.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Overall Summary of Adverse Events During ST+LT Treatment Period</title>
        <description>AE=any new untoward medical occurrence or worsening of a pre-existing medical condition which does not necessarily have a causal relationship with this treatment. SAE=any untoward medical occurrence that at any dose: results in death, is life-threatening, requires inpatient hospitalization or causes prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect, results in development of drug dependency or drug abuse, is an important medical event. Related events=relationship of certain, probable, possible, or missing.</description>
        <time_frame>AEs: up to last treatment day + 1 day or last visit; SAEs: up to last treatment day + 30 days or last visit + 30 days. Mean duration of exposure was 109 weeks in 10 mg arm, 94.7 weeks in 2.5 mg arm, 103 weeks in 5 mg arm, and 98.4 weeks in placebo arm.</time_frame>
        <population>All treated participants</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg</title>
            <description>Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg</title>
            <description>Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
            <description>Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Summary of Adverse Events During ST+LT Treatment Period</title>
          <description>AE=any new untoward medical occurrence or worsening of a pre-existing medical condition which does not necessarily have a causal relationship with this treatment. SAE=any untoward medical occurrence that at any dose: results in death, is life-threatening, requires inpatient hospitalization or causes prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect, results in development of drug dependency or drug abuse, is an important medical event. Related events=relationship of certain, probable, possible, or missing.</description>
          <population>All treated participants</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="102"/>
                <count group_id="O2" value="106"/>
                <count group_id="O3" value="98"/>
                <count group_id="O4" value="95"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>At Least 1 AE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89"/>
                    <measurement group_id="O2" value="94"/>
                    <measurement group_id="O3" value="87"/>
                    <measurement group_id="O4" value="77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At Least 1 Related AE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                    <measurement group_id="O2" value="23"/>
                    <measurement group_id="O3" value="25"/>
                    <measurement group_id="O4" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Deaths</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At Least 1 SAE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="18"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At Least 1 Related SAE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discontinuations Due to SAEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discontinuations Due to AEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Marked Laboratory Abnormalities - During ST + LT Treatment Period</title>
        <description>A laboratory value was considered a marked abnormality if it is outside the pre-defined criteria for marked abnormality and the on-treatment value was more extreme (farther from the limit) than the baseline value. Pre-Rx=pretreatment; ULN=upper limit of normal; ALP=alkaline phosphatase; AST=aspartate aminotransferase; ALT=alanine aminotransferase; unspec=unspecified; sodium serum low: &lt;0.9 x Pre-Rx &amp; &lt;=130mEq/L / high: &gt;1.1 x Pre-Rx &amp; &gt;=150mEq/L; potassium, serum low: &lt;=0.8 x Pre-Rx &amp; &gt;=6.0mEq/L / high: 1.2 x Pre-Rx &amp; &gt;=6.0mEq/L; LLN=lower limit of normal.</description>
        <time_frame>Lab assessments taken during and up to 14 days after the last dose of study drug during the ST + LT Treatment Period. Mean duration of exposure was 109 weeks in 10 mg arm, 94.7 weeks in 2.5 mg arm, 103 weeks in 5 mg arm, and 98.4 weeks in placebo arm.</time_frame>
        <population>Number of Participants Analyzed=Treated participants; n=number of treated subjects with baseline value and at least one value during the ST + LT treatment period</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg</title>
            <description>Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg</title>
            <description>Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
            <description>Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)</description>
          </group>
        </group_list>
        <measure>
          <title>Marked Laboratory Abnormalities - During ST + LT Treatment Period</title>
          <description>A laboratory value was considered a marked abnormality if it is outside the pre-defined criteria for marked abnormality and the on-treatment value was more extreme (farther from the limit) than the baseline value. Pre-Rx=pretreatment; ULN=upper limit of normal; ALP=alkaline phosphatase; AST=aspartate aminotransferase; ALT=alanine aminotransferase; unspec=unspecified; sodium serum low: &lt;0.9 x Pre-Rx &amp; &lt;=130mEq/L / high: &gt;1.1 x Pre-Rx &amp; &gt;=150mEq/L; potassium, serum low: &lt;=0.8 x Pre-Rx &amp; &gt;=6.0mEq/L / high: 1.2 x Pre-Rx &amp; &gt;=6.0mEq/L; LLN=lower limit of normal.</description>
          <population>Number of Participants Analyzed=Treated participants; n=number of treated subjects with baseline value and at least one value during the ST + LT treatment period</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="102"/>
                <count group_id="O2" value="106"/>
                <count group_id="O3" value="98"/>
                <count group_id="O4" value="95"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Hemoglobin &lt; 8 g/dL (n=101, 105, 97, 93)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hematocrit &lt; 0.75 x pre-Rx (n=101, 105, 97, 93)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Platelets &lt; 50 x 10^9 c/L (n=100, 104, 94, 93)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Platelets &gt; 1.5 x ULN (n=100,104, 94, 93)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Leukocytes &lt; 2 x 1000 c/µL (n=101, 105, 97, 93)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Neutrophils+Bands &lt;1x1000 c/µL(n=101, 105, 97, 93)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Eosinophils &gt;0.9x1000 c/µL (n=101, 105, 97, 93)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lymphocytes &lt;=0.75x1000 c/µL (n=101, 105, 97, 93)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ALP &gt;3 x pre-Rx and &gt;ULN (n=101,105, 97, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ALP &gt;1.5 x ULN (n=101, 105, 97, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AST &gt;3 x ULN (n=101, 105, 97, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AST &gt;5 x ULN (n=101, 105, 97, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AST &gt;10 x ULN (n=101, 105, 97, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AST &gt;20 x ULN (n=101, 105, 97, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ALT &gt;3 x ULN (n=101, 105, 97, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ALT &gt;5 x ULN (n=101, 105, 97, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ALT &gt;10 x ULN (n=101, 105, 97, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ALT &gt;20 x ULN (n=101, 105, 97, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bilirubin Total &gt;2mg/dL (n=101, 105, 97, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bilirubin Total &gt;1.5xULN (n=101, 105, 97, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bilirubin Total &gt;2xULN (n=101, 105, 97, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BUN &gt;2 x pre-Rx and &gt;ULN (n=101, 105, 97, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Creatinine &gt;2.5 mg/dL (n=101, 105, 97, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Glucose, Serum Fasting &lt; 50 mg/dL (n=0, 0, 0, 0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Glucose, Serum Fasting &gt; 500 mg/dL (n=0, 0, 0, 0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Glucose, Serum Unspec. &lt; 50 mg/dL (n=0,0,0,0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Glucose, Serum Unspec. &gt; 500 mg/dL (n=0,0,0,0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Glucose, Plasma Fasting&lt;50mg/dL(n=101, 104, 96,94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Glucose,Plasma Fasting&gt;500mg/dL(n=101, 104, 96,94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Glucose, Plasma Unspec.&lt;50mg/dL(n=102, 105, 98,95)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Glucose,Plasma Unspec.&gt;500mg/dL(n=102, 105, 98,95)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sodium,Serum Low (see above) (n=101, 105, 97, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sodium,Serum High(see above) (n=101, 105, 97, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Potassium,Serum Low(see above)(n=101, 105, 97, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Potassium, Serum High(see above)(n=101,105,97,94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chloride &lt; 90 mEq/L (n=101, 105, 97, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chloride &gt; 120 mEq/L (n=101, 105, 97, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Albumin &lt; 0.9 LLN (n=101, 105, 97, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Creatine Kinase &gt; 5 x ULN (n=101, 105, 97, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Uric Acid &gt; 1.5 x ULN (n=0, 0, 0, 0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Protein Urine, &gt;=2-4 (n=99, 103, 94, 92)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Blood Urine, &gt;=2-4 (n=99, 103, 94, 92)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Red Blood Cells Urine &gt;=2-4 (n=95, 97, 89, 88)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White Blood Cells Urine &gt;=2-4 (n=95, 97, 89, 88)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="19"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Baseline and Changes From Baseline in Hemoglobin During the ST + LT Period</title>
        <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
        <population>Treated participants; n=number of treated participants with measurement at time point</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg</title>
            <description>Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg</title>
            <description>Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
            <description>Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline and Changes From Baseline in Hemoglobin During the ST + LT Period</title>
          <population>Treated participants; n=number of treated participants with measurement at time point</population>
          <units>g/dL</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="102"/>
                <count group_id="O2" value="106"/>
                <count group_id="O3" value="98"/>
                <count group_id="O4" value="95"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (BL) (Week 0) (n=102, 106, 98, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.49" spread="0.133"/>
                    <measurement group_id="O2" value="14.45" spread="0.125"/>
                    <measurement group_id="O3" value="14.47" spread="0.137"/>
                    <measurement group_id="O4" value="14.50" spread="0.131"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 2 (n=95,100, 93, 87)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.21" spread="0.069"/>
                    <measurement group_id="O2" value="-0.13" spread="0.065"/>
                    <measurement group_id="O3" value="-0.22" spread="0.075"/>
                    <measurement group_id="O4" value="-0.09" spread="0.078"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 4 (n=92, 99, 91, 91)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.16" spread="0.071"/>
                    <measurement group_id="O2" value="-0.15" spread="0.082"/>
                    <measurement group_id="O3" value="-0.09" spread="0.069"/>
                    <measurement group_id="O4" value="0.10" spread="0.063"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 6 (n=91, 96, 87, 82)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.12" spread="0.069"/>
                    <measurement group_id="O2" value="-0.00" spread="0.074"/>
                    <measurement group_id="O3" value="-0.07" spread="0.073"/>
                    <measurement group_id="O4" value="0.04" spread="0.069"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 8 (n=92, 90, 91, 79)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.00" spread="0.068"/>
                    <measurement group_id="O2" value="0.04" spread="0.080"/>
                    <measurement group_id="O3" value="-0.02" spread="0.071"/>
                    <measurement group_id="O4" value="0.09" spread="0.074"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 10 (n=70, 76, 69, 63)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.082"/>
                    <measurement group_id="O2" value="-0.20" spread="0.096"/>
                    <measurement group_id="O3" value="-0.13" spread="0.086"/>
                    <measurement group_id="O4" value="0.04" spread="0.097"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 12 (n=85, 88, 87, 82)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.04" spread="0.074"/>
                    <measurement group_id="O2" value="-0.07" spread="0.079"/>
                    <measurement group_id="O3" value="-0.07" spread="0.083"/>
                    <measurement group_id="O4" value="0.16" spread="0.075"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 14 (n=76, 80, 81, 75)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.09" spread="0.090"/>
                    <measurement group_id="O2" value="-0.05" spread="0.078"/>
                    <measurement group_id="O3" value="-0.12" spread="0.085"/>
                    <measurement group_id="O4" value="-0.03" spread="0.083"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 16 (n=90, 91, 83, 71)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.10" spread="0.087"/>
                    <measurement group_id="O2" value="0.01" spread="0.078"/>
                    <measurement group_id="O3" value="0.00" spread="0.087"/>
                    <measurement group_id="O4" value="0.04" spread="0.084"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 18 (n=78, 75, 82, 71)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.26" spread="0.083"/>
                    <measurement group_id="O2" value="-0.10" spread="0.079"/>
                    <measurement group_id="O3" value="-0.07" spread="0.092"/>
                    <measurement group_id="O4" value="-0.03" spread="0.099"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 20 (n=83, 80, 78, 72)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.16" spread="0.079"/>
                    <measurement group_id="O2" value="-0.14" spread="0.093"/>
                    <measurement group_id="O3" value="-0.25" spread="0.081"/>
                    <measurement group_id="O4" value="-0.19" spread="0.086"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 22 (n=78, 74, 76, 65)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.35" spread="0.075"/>
                    <measurement group_id="O2" value="-0.23" spread="0.092"/>
                    <measurement group_id="O3" value="-0.36" spread="0.087"/>
                    <measurement group_id="O4" value="-0.18" spread="0.102"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 24 (n=83, 82, 78, 74)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.37" spread="0.079"/>
                    <measurement group_id="O2" value="-0.25" spread="0.080"/>
                    <measurement group_id="O3" value="-0.32" spread="0.078"/>
                    <measurement group_id="O4" value="-0.14" spread="0.100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 30 (n=77, 78, 79, 67)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.25" spread="0.081"/>
                    <measurement group_id="O2" value="-0.29" spread="0.097"/>
                    <measurement group_id="O3" value="-0.19" spread="0.086"/>
                    <measurement group_id="O4" value="-0.18" spread="0.101"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 37 (n=75, 73, 70, 62)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.31" spread="0.094"/>
                    <measurement group_id="O2" value="-0.22" spread="0.087"/>
                    <measurement group_id="O3" value="-0.06" spread="0.090"/>
                    <measurement group_id="O4" value="-0.33" spread="0.093"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 50 (n=67, 71, 71, 61)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.17" spread="0.082"/>
                    <measurement group_id="O2" value="0.06" spread="0.103"/>
                    <measurement group_id="O3" value="-0.02" spread="0.107"/>
                    <measurement group_id="O4" value="-0.01" spread="0.100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 63 (n=61, 66, 67, 55)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.18" spread="0.112"/>
                    <measurement group_id="O2" value="-0.11" spread="0.096"/>
                    <measurement group_id="O3" value="0.07" spread="0.102"/>
                    <measurement group_id="O4" value="0.08" spread="0.139"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 76 (n=51, 59, 63, 49)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.27" spread="0.125"/>
                    <measurement group_id="O2" value="-0.19" spread="0.119"/>
                    <measurement group_id="O3" value="-0.07" spread="0.102"/>
                    <measurement group_id="O4" value="-0.10" spread="0.117"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 89 (n=49, 58, 56, 42)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.18" spread="0.109"/>
                    <measurement group_id="O2" value="-0.09" spread="0.097"/>
                    <measurement group_id="O3" value="-0.04" spread="0.103"/>
                    <measurement group_id="O4" value="-0.10" spread="0.109"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 102 (n=40, 49, 51, 40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.32" spread="0.132"/>
                    <measurement group_id="O2" value="-0.00" spread="0.129"/>
                    <measurement group_id="O3" value="-0.07" spread="0.121"/>
                    <measurement group_id="O4" value="-0.29" spread="0.131"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 115 (n=34, 43, 43, 35)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.41" spread="0.132"/>
                    <measurement group_id="O2" value="-0.07" spread="0.137"/>
                    <measurement group_id="O3" value="-0.18" spread="0.147"/>
                    <measurement group_id="O4" value="-0.19" spread="0.116"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 128 (n=30, 40, 40, 30)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.38" spread="0.125"/>
                    <measurement group_id="O2" value="-0.17" spread="0.128"/>
                    <measurement group_id="O3" value="-0.25" spread="0.132"/>
                    <measurement group_id="O4" value="-0.33" spread="0.124"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 141 (n=28, 39, 34, 28)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.40" spread="0.125"/>
                    <measurement group_id="O2" value="-0.35" spread="0.156"/>
                    <measurement group_id="O3" value="-0.15" spread="0.169"/>
                    <measurement group_id="O4" value="-0.36" spread="0.104"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 154 (n=26, 34, 31, 24)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.45" spread="0.160"/>
                    <measurement group_id="O2" value="-0.37" spread="0.186"/>
                    <measurement group_id="O3" value="-0.24" spread="0.166"/>
                    <measurement group_id="O4" value="-0.25" spread="0.130"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 167 (n=24, 33, 30, 26)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.51" spread="0.178"/>
                    <measurement group_id="O2" value="-0.05" spread="0.161"/>
                    <measurement group_id="O3" value="-0.03" spread="0.170"/>
                    <measurement group_id="O4" value="-0.24" spread="0.148"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 180 (n=21, 28, 28, 26)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.38" spread="0.178"/>
                    <measurement group_id="O2" value="-0.08" spread="0.176"/>
                    <measurement group_id="O3" value="-0.08" spread="0.167"/>
                    <measurement group_id="O4" value="-0.61" spread="0.169"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 193 (n=19, 26, 26, 23)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.45" spread="0.212"/>
                    <measurement group_id="O2" value="-0.03" spread="0.190"/>
                    <measurement group_id="O3" value="-0.16" spread="0.178"/>
                    <measurement group_id="O4" value="-0.39" spread="0.175"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 206 (n=17, 22, 24, 21)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.51" spread="0.221"/>
                    <measurement group_id="O2" value="-0.07" spread="0.195"/>
                    <measurement group_id="O3" value="0.10" spread="0.124"/>
                    <measurement group_id="O4" value="-0.32" spread="0.174"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Baseline and Changes From Baseline in Hematocrit During the ST + LT Period</title>
        <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
        <population>Treated participants; n=number of treated participants with measurement at time point</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg</title>
            <description>Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg</title>
            <description>Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
            <description>Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline and Changes From Baseline in Hematocrit During the ST + LT Period</title>
          <population>Treated participants; n=number of treated participants with measurement at time point</population>
          <units>percentage red blood cells</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="102"/>
                <count group_id="O2" value="106"/>
                <count group_id="O3" value="98"/>
                <count group_id="O4" value="95"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (BL) (Week 0) (n=102, 106, 98, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.5" spread="0.35"/>
                    <measurement group_id="O2" value="42.8" spread="0.35"/>
                    <measurement group_id="O3" value="42.7" spread="0.37"/>
                    <measurement group_id="O4" value="42.8" spread="0.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 2 (n=95,100, 93, 87)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.4" spread="0.22"/>
                    <measurement group_id="O2" value="-0.2" spread="0.20"/>
                    <measurement group_id="O3" value="-0.7" spread="0.21"/>
                    <measurement group_id="O4" value="-0.4" spread="0.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 4 (n=92, 99, 91, 91)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.2" spread="0.21"/>
                    <measurement group_id="O2" value="-0.2" spread="0.24"/>
                    <measurement group_id="O3" value="-0.1" spread="0.22"/>
                    <measurement group_id="O4" value="0.3" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 6 (n=91, 96, 87, 82)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="0.19"/>
                    <measurement group_id="O2" value="0.3" spread="0.24"/>
                    <measurement group_id="O3" value="0.0" spread="0.24"/>
                    <measurement group_id="O4" value="0.3" spread="0.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 8 (n=92, 90, 91, 79)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.5" spread="0.22"/>
                    <measurement group_id="O2" value="0.4" spread="0.27"/>
                    <measurement group_id="O3" value="0.2" spread="0.20"/>
                    <measurement group_id="O4" value="0.5" spread="0.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 10 (n=70, 76, 69, 63)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6" spread="0.25"/>
                    <measurement group_id="O2" value="-0.0" spread="0.31"/>
                    <measurement group_id="O3" value="-0.2" spread="0.24"/>
                    <measurement group_id="O4" value="0.5" spread="0.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 12 (n=85, 88, 87, 82)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6" spread="0.25"/>
                    <measurement group_id="O2" value="0.4" spread="0.26"/>
                    <measurement group_id="O3" value="0.6" spread="0.26"/>
                    <measurement group_id="O4" value="0.7" spread="0.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 14 (n=76, 80, 81, 75)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6" spread="0.27"/>
                    <measurement group_id="O2" value="0.6" spread="0.27"/>
                    <measurement group_id="O3" value="0.2" spread="0.27"/>
                    <measurement group_id="O4" value="0.2" spread="0.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 16 (n=90. 91, 83, 71)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.5" spread="0.24"/>
                    <measurement group_id="O2" value="0.7" spread="0.26"/>
                    <measurement group_id="O3" value="0.6" spread="0.25"/>
                    <measurement group_id="O4" value="0.3" spread="0.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 18 (n=78, 75, 82, 71)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="0.27"/>
                    <measurement group_id="O2" value="0.4" spread="0.29"/>
                    <measurement group_id="O3" value="0.3" spread="0.24"/>
                    <measurement group_id="O4" value="0.4" spread="0.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 20 (n=83, 80, 78, 72)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.7" spread="0.25"/>
                    <measurement group_id="O2" value="0.4" spread="0.31"/>
                    <measurement group_id="O3" value="0.1" spread="0.26"/>
                    <measurement group_id="O4" value="0.2" spread="0.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 22 (n=78, 74, 76, 65)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="0.27"/>
                    <measurement group_id="O2" value="0.2" spread="0.32"/>
                    <measurement group_id="O3" value="-0.3" spread="0.26"/>
                    <measurement group_id="O4" value="0.5" spread="0.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 24 (n=83, 82, 78, 74)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0" spread="0.24"/>
                    <measurement group_id="O2" value="0.2" spread="0.28"/>
                    <measurement group_id="O3" value="-0.1" spread="0.24"/>
                    <measurement group_id="O4" value="0.5" spread="0.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 30 (n=77, 78, 79, 67)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.5" spread="0.30"/>
                    <measurement group_id="O2" value="-0.1" spread="0.36"/>
                    <measurement group_id="O3" value="0.2" spread="0.30"/>
                    <measurement group_id="O4" value="0.4" spread="0.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 37 (n=75, 73, 70, 62)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0" spread="0.30"/>
                    <measurement group_id="O2" value="-0.1" spread="0.27"/>
                    <measurement group_id="O3" value="0.4" spread="0.29"/>
                    <measurement group_id="O4" value="-0.4" spread="0.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 50 (n=67, 71, 71, 61)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="0.29"/>
                    <measurement group_id="O2" value="0.3" spread="0.33"/>
                    <measurement group_id="O3" value="0.1" spread="0.34"/>
                    <measurement group_id="O4" value="0.2" spread="0.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 63 (n=61, 66, 67, 55)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="0.34"/>
                    <measurement group_id="O2" value="0.1" spread="0.31"/>
                    <measurement group_id="O3" value="0.6" spread="0.34"/>
                    <measurement group_id="O4" value="0.7" spread="0.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 76 (n=51, 59, 63, 49)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.7" spread="0.39"/>
                    <measurement group_id="O2" value="0.5" spread="0.40"/>
                    <measurement group_id="O3" value="0.7" spread="0.35"/>
                    <measurement group_id="O4" value="0.8" spread="0.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 89 (n=49, 58, 56, 42)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9" spread="0.37"/>
                    <measurement group_id="O2" value="0.9" spread="0.34"/>
                    <measurement group_id="O3" value="1.2" spread="0.35"/>
                    <measurement group_id="O4" value="0.4" spread="0.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 102 (n=40, 49, 51, 40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.2" spread="0.37"/>
                    <measurement group_id="O2" value="0.5" spread="0.40"/>
                    <measurement group_id="O3" value="-0.0" spread="0.34"/>
                    <measurement group_id="O4" value="-0.7" spread="0.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 115 (n=34, 43, 43, 35)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.0" spread="0.42"/>
                    <measurement group_id="O2" value="0.6" spread="0.42"/>
                    <measurement group_id="O3" value="0.2" spread="0.46"/>
                    <measurement group_id="O4" value="0.2" spread="0.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 128 (n=30, 40, 40, 30)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="0.42"/>
                    <measurement group_id="O2" value="0.3" spread="0.43"/>
                    <measurement group_id="O3" value="0.0" spread="0.43"/>
                    <measurement group_id="O4" value="-0.1" spread="0.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 141 (n=28, 39, 34, 28)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.1" spread="0.42"/>
                    <measurement group_id="O2" value="-0.1" spread="0.48"/>
                    <measurement group_id="O3" value="0.2" spread="0.50"/>
                    <measurement group_id="O4" value="-0.2" spread="0.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 154 (n=26, 34, 31, 24)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.8" spread="0.45"/>
                    <measurement group_id="O2" value="-0.8" spread="0.43"/>
                    <measurement group_id="O3" value="-1.0" spread="0.51"/>
                    <measurement group_id="O4" value="-0.3" spread="0.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 167 (n=24, 33, 30, 26)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.1" spread="0.53"/>
                    <measurement group_id="O2" value="0.2" spread="0.46"/>
                    <measurement group_id="O3" value="0.2" spread="0.56"/>
                    <measurement group_id="O4" value="-0.4" spread="0.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 180 (n=21, 28, 28, 26)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.1" spread="0.55"/>
                    <measurement group_id="O2" value="0.6" spread="0.58"/>
                    <measurement group_id="O3" value="1.0" spread="0.53"/>
                    <measurement group_id="O4" value="-0.5" spread="0.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 193 (n=19, 26, 26, 23)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6" spread="0.65"/>
                    <measurement group_id="O2" value="1.1" spread="0.55"/>
                    <measurement group_id="O3" value="0.5" spread="0.61"/>
                    <measurement group_id="O4" value="-0.0" spread="0.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 206 (n=17, 22, 24, 21)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.4" spread="0.54"/>
                    <measurement group_id="O2" value="0.2" spread="0.52"/>
                    <measurement group_id="O3" value="0.2" spread="0.42"/>
                    <measurement group_id="O4" value="-0.5" spread="0.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Baseline and Changes From Baseline in Red Blood Cell Counts (x 10^6 c/µL) During the ST + LT Period</title>
        <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
        <population>Treated participants; n=number of treated participants with measurement at time point</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg</title>
            <description>Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg</title>
            <description>Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
            <description>Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline and Changes From Baseline in Red Blood Cell Counts (x 10^6 c/µL) During the ST + LT Period</title>
          <population>Treated participants; n=number of treated participants with measurement at time point</population>
          <units>x 10^6 c/µL</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="102"/>
                <count group_id="O2" value="106"/>
                <count group_id="O3" value="98"/>
                <count group_id="O4" value="95"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (BL) (Week 0) (n=102, 106, 98, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.80" spread="0.038"/>
                    <measurement group_id="O2" value="4.80" spread="0.042"/>
                    <measurement group_id="O3" value="4.82" spread="0.039"/>
                    <measurement group_id="O4" value="4.82" spread="0.043"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 2 (n=95,100, 93, 87</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.06" spread="0.021"/>
                    <measurement group_id="O2" value="-0.04" spread="0.021"/>
                    <measurement group_id="O3" value="-0.08" spread="0.023"/>
                    <measurement group_id="O4" value="-0.05" spread="0.023"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 4 (n=92, 99, 91, 91)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.01" spread="0.023"/>
                    <measurement group_id="O2" value="-0.04" spread="0.026"/>
                    <measurement group_id="O3" value="-0.02" spread="0.022"/>
                    <measurement group_id="O4" value="0.04" spread="0.020"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 6 (n=91, 96, 87, 82)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.022"/>
                    <measurement group_id="O2" value="0.02" spread="0.024"/>
                    <measurement group_id="O3" value="0.00" spread="0.026"/>
                    <measurement group_id="O4" value="0.02" spread="0.023"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 8 (n=92, 90, 91, 79)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.020"/>
                    <measurement group_id="O2" value="0.03" spread="0.026"/>
                    <measurement group_id="O3" value="0.03" spread="0.023"/>
                    <measurement group_id="O4" value="0.05" spread="0.023"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 10 (n=70, 76, 69, 63)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.026"/>
                    <measurement group_id="O2" value="-0.03" spread="0.033"/>
                    <measurement group_id="O3" value="-0.02" spread="0.026"/>
                    <measurement group_id="O4" value="0.07" spread="0.032"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 12 (n=85, 88, 87, 82)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.025"/>
                    <measurement group_id="O2" value="0.03" spread="0.029"/>
                    <measurement group_id="O3" value="0.07" spread="0.025"/>
                    <measurement group_id="O4" value="0.08" spread="0.026"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 14 (n=76, 80, 81, 75)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.027"/>
                    <measurement group_id="O2" value="0.03" spread="0.029"/>
                    <measurement group_id="O3" value="0.04" spread="0.030"/>
                    <measurement group_id="O4" value="0.04" spread="0.025"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 16 (n=90, 91, 83, 71)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.06" spread="0.027"/>
                    <measurement group_id="O2" value="0.08" spread="0.028"/>
                    <measurement group_id="O3" value="0.08" spread="0.027"/>
                    <measurement group_id="O4" value="0.06" spread="0.028"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 18 (n=78, 75, 82, 71)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.024"/>
                    <measurement group_id="O2" value="0.04" spread="0.029"/>
                    <measurement group_id="O3" value="0.05" spread="0.028"/>
                    <measurement group_id="O4" value="0.04" spread="0.030"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 20 (n=83, 80, 78, 72)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.023"/>
                    <measurement group_id="O2" value="0.02" spread="0.031"/>
                    <measurement group_id="O3" value="0.01" spread="0.025"/>
                    <measurement group_id="O4" value="-0.01" spread="0.026"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 22 (n=78, 74, 76, 65)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.01" spread="0.023"/>
                    <measurement group_id="O2" value="-0.01" spread="0.033"/>
                    <measurement group_id="O3" value="-0.05" spread="0.029"/>
                    <measurement group_id="O4" value="-0.01" spread="0.032"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 24 (n=83, 82, 78, 74)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.04" spread="0.024"/>
                    <measurement group_id="O2" value="-0.04" spread="0.029"/>
                    <measurement group_id="O3" value="-0.03" spread="0.026"/>
                    <measurement group_id="O4" value="-0.01" spread="0.031"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 30 (n=77, 78, 79, 67)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.027"/>
                    <measurement group_id="O2" value="-0.07" spread="0.035"/>
                    <measurement group_id="O3" value="-0.01" spread="0.031"/>
                    <measurement group_id="O4" value="-0.03" spread="0.034"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 37 (n=75, 73, 70, 62)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.04" spread="0.028"/>
                    <measurement group_id="O2" value="-0.04" spread="0.027"/>
                    <measurement group_id="O3" value="0.04" spread="0.031"/>
                    <measurement group_id="O4" value="-0.09" spread="0.033"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 50 (n=67, 71, 71, 61)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.027"/>
                    <measurement group_id="O2" value="0.04" spread="0.031"/>
                    <measurement group_id="O3" value="0.02" spread="0.034"/>
                    <measurement group_id="O4" value="0.01" spread="0.026"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 63 (n=61, 66, 67, 55)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.032"/>
                    <measurement group_id="O2" value="-0.01" spread="0.028"/>
                    <measurement group_id="O3" value="0.08" spread="0.034"/>
                    <measurement group_id="O4" value="0.05" spread="0.045"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 76 (n=51, 59, 63, 49)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.07" spread="0.037"/>
                    <measurement group_id="O2" value="-0.07" spread="0.038"/>
                    <measurement group_id="O3" value="0.00" spread="0.036"/>
                    <measurement group_id="O4" value="-0.03" spread="0.037"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 89 (n=49, 58, 56, 42)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.04" spread="0.034"/>
                    <measurement group_id="O2" value="-0.06" spread="0.028"/>
                    <measurement group_id="O3" value="-0.01" spread="0.035"/>
                    <measurement group_id="O4" value="-0.07" spread="0.031"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 102 (n=40, 49, 51, 40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.10" spread="0.040"/>
                    <measurement group_id="O2" value="-0.03" spread="0.043"/>
                    <measurement group_id="O3" value="-0.03" spread="0.037"/>
                    <measurement group_id="O4" value="-0.13" spread="0.037"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 115 (n=34, 43, 43, 35)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.04" spread="0.039"/>
                    <measurement group_id="O2" value="-0.01" spread="0.043"/>
                    <measurement group_id="O3" value="-0.02" spread="0.044"/>
                    <measurement group_id="O4" value="-0.06" spread="0.033"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 128 (n=30, 40, 40, 30)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.05" spread="0.037"/>
                    <measurement group_id="O2" value="-0.07" spread="0.039"/>
                    <measurement group_id="O3" value="-0.04" spread="0.048"/>
                    <measurement group_id="O4" value="-0.10" spread="0.039"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 141 (n=28, 39, 34, 28)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.10" spread="0.037"/>
                    <measurement group_id="O2" value="-0.13" spread="0.048"/>
                    <measurement group_id="O3" value="-0.02" spread="0.052"/>
                    <measurement group_id="O4" value="-0.11" spread="0.041"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 154 (n=26, 35, 31, 24)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.13" spread="0.037"/>
                    <measurement group_id="O2" value="-0.13" spread="0.045"/>
                    <measurement group_id="O3" value="-0.08" spread="0.054"/>
                    <measurement group_id="O4" value="-0.09" spread="0.045"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 167 (n=24, 33, 30, 26)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.11" spread="0.052"/>
                    <measurement group_id="O2" value="-0.04" spread="0.049"/>
                    <measurement group_id="O3" value="-0.01" spread="0.057"/>
                    <measurement group_id="O4" value="-0.10" spread="0.044"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 180 (n=21, 28, 28, 26)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.05" spread="0.041"/>
                    <measurement group_id="O2" value="-0.08" spread="0.059"/>
                    <measurement group_id="O3" value="-0.01" spread="0.054"/>
                    <measurement group_id="O4" value="-0.17" spread="0.056"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 193 (n=19, 26, 26, 23)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.05" spread="0.054"/>
                    <measurement group_id="O2" value="-0.06" spread="0.061"/>
                    <measurement group_id="O3" value="-0.02" spread="0.057"/>
                    <measurement group_id="O4" value="-0.10" spread="0.062"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 206 (n=17, 22, 24, 21)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.03" spread="0.064"/>
                    <measurement group_id="O2" value="-0.06" spread="0.058"/>
                    <measurement group_id="O3" value="0.06" spread="0.043"/>
                    <measurement group_id="O4" value="-0.08" spread="0.055"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Baseline and Changes From Baseline in Platelet Counts (x 10^9 c/L) During the ST + LT Period</title>
        <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
        <population>Treated participants; n=number of treated participants with measurement at time point</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg</title>
            <description>Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg</title>
            <description>Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
            <description>Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline and Changes From Baseline in Platelet Counts (x 10^9 c/L) During the ST + LT Period</title>
          <population>Treated participants; n=number of treated participants with measurement at time point</population>
          <units>x 10^9 c/L</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="102"/>
                <count group_id="O2" value="106"/>
                <count group_id="O3" value="98"/>
                <count group_id="O4" value="95"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (BL) (Week 0) (n=101, 106, 96, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="251.1" spread="6.33"/>
                    <measurement group_id="O2" value="253.1" spread="5.93"/>
                    <measurement group_id="O3" value="261.6" spread="6.71"/>
                    <measurement group_id="O4" value="259.8" spread="6.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 2 (n=92, 96, 85, 82)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8" spread="3.40"/>
                    <measurement group_id="O2" value="4.4" spread="2.82"/>
                    <measurement group_id="O3" value="2.2" spread="3.72"/>
                    <measurement group_id="O4" value="9.5" spread="3.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 4 (n=88, 97, 90, 90)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.2" spread="3.39"/>
                    <measurement group_id="O2" value="8.6" spread="3.41"/>
                    <measurement group_id="O3" value="5.6" spread="3.11"/>
                    <measurement group_id="O4" value="11.3" spread="2.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 6 (n=88, 93, 84, 81)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.3" spread="2.85"/>
                    <measurement group_id="O2" value="4.3" spread="3.53"/>
                    <measurement group_id="O3" value="-0.2" spread="3.39"/>
                    <measurement group_id="O4" value="9.5" spread="3.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 8 (n=86, 85, 86, 77)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4" spread="3.21"/>
                    <measurement group_id="O2" value="1.0" spread="3.13"/>
                    <measurement group_id="O3" value="-4.3" spread="2.94"/>
                    <measurement group_id="O4" value="4.0" spread="4.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 10 (n=68, 75, 67, 62)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.8" spread="3.87"/>
                    <measurement group_id="O2" value="3.0" spread="3.99"/>
                    <measurement group_id="O3" value="-4.4" spread="4.44"/>
                    <measurement group_id="O4" value="7.1" spread="3.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 12 (n=83, 84, 85, 82)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6.3" spread="3.58"/>
                    <measurement group_id="O2" value="-1.3" spread="3.85"/>
                    <measurement group_id="O3" value="-4.8" spread="4.14"/>
                    <measurement group_id="O4" value="4.0" spread="3.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 14 (n=72, 79, 77, 74)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2" spread="3.91"/>
                    <measurement group_id="O2" value="3.2" spread="4.75"/>
                    <measurement group_id="O3" value="-3.7" spread="4.21"/>
                    <measurement group_id="O4" value="5.2" spread="3.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 16 (n=86, 88, 81, 69)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.3" spread="3.73"/>
                    <measurement group_id="O2" value="1.1" spread="3.66"/>
                    <measurement group_id="O3" value="-6.0" spread="3.74"/>
                    <measurement group_id="O4" value="3.2" spread="3.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 18 (n=77, 71, 79, 70)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.1" spread="3.93"/>
                    <measurement group_id="O2" value="2.0" spread="4.06"/>
                    <measurement group_id="O3" value="-2.7" spread="3.63"/>
                    <measurement group_id="O4" value="5.8" spread="3.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 20 (n=78, 78, 72, 70)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.9" spread="3.87"/>
                    <measurement group_id="O2" value="-4.8" spread="4.39"/>
                    <measurement group_id="O3" value="-8.3" spread="3.94"/>
                    <measurement group_id="O4" value="-1.3" spread="3.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 22 (n=74, 72, 73, 62)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="4.64"/>
                    <measurement group_id="O2" value="-2.5" spread="3.91"/>
                    <measurement group_id="O3" value="-5.4" spread="4.01"/>
                    <measurement group_id="O4" value="5.0" spread="3.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 24 (n=80, 76, 73, 72)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-7.1" spread="3.94"/>
                    <measurement group_id="O2" value="-6.0" spread="4.00"/>
                    <measurement group_id="O3" value="-15.5" spread="4.54"/>
                    <measurement group_id="O4" value="-3.0" spread="3.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 30 (n=73, 74, 74, 67)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.0" spread="5.66"/>
                    <measurement group_id="O2" value="-3.3" spread="4.37"/>
                    <measurement group_id="O3" value="-9.9" spread="4.34"/>
                    <measurement group_id="O4" value="4.5" spread="4.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 37 (n=70, 68, 66, 59)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-14.3" spread="3.85"/>
                    <measurement group_id="O2" value="-8.1" spread="4.71"/>
                    <measurement group_id="O3" value="-15.6" spread="3.93"/>
                    <measurement group_id="O4" value="0.1" spread="4.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 50 (n=66, 67, 66, 59)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.5" spread="4.25"/>
                    <measurement group_id="O2" value="-5.6" spread="4.39"/>
                    <measurement group_id="O3" value="-11.5" spread="3.76"/>
                    <measurement group_id="O4" value="6.6" spread="6.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 63 (n=59, 64, 65, 54)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.1" spread="4.57"/>
                    <measurement group_id="O2" value="-3.4" spread="4.24"/>
                    <measurement group_id="O3" value="-6.3" spread="4.23"/>
                    <measurement group_id="O4" value="10.2" spread="5.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 76 (n=50, 58, 61, 49)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.0" spread="5.64"/>
                    <measurement group_id="O2" value="-1.5" spread="4.56"/>
                    <measurement group_id="O3" value="-6.0" spread="3.68"/>
                    <measurement group_id="O4" value="1.2" spread="4.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 89 (n=47, 56, 54, 42)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.5" spread="5.29"/>
                    <measurement group_id="O2" value="1.9" spread="5.02"/>
                    <measurement group_id="O3" value="-6.7" spread="3.83"/>
                    <measurement group_id="O4" value="2.7" spread="4.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 102 (n=39, 47, 49, 39)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.2" spread="7.75"/>
                    <measurement group_id="O2" value="-2.3" spread="5.34"/>
                    <measurement group_id="O3" value="-4.8" spread="3.65"/>
                    <measurement group_id="O4" value="9.7" spread="7.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 115 (n=33, 41, 41, 34)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.0" spread="8.04"/>
                    <measurement group_id="O2" value="-8.8" spread="4.96"/>
                    <measurement group_id="O3" value="-12.0" spread="4.23"/>
                    <measurement group_id="O4" value="9.2" spread="7.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 128 (n=30, 38, 39, 30)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.8" spread="5.74"/>
                    <measurement group_id="O2" value="-2.1" spread="5.39"/>
                    <measurement group_id="O3" value="-2.6" spread="5.04"/>
                    <measurement group_id="O4" value="2.6" spread="7.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 141 (n=27, 39, 33, 27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.1" spread="5.34"/>
                    <measurement group_id="O2" value="-4.6" spread="5.16"/>
                    <measurement group_id="O3" value="-0.3" spread="4.73"/>
                    <measurement group_id="O4" value="-1.3" spread="8.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 154 (n=25, 35, 31, 23)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.0" spread="6.95"/>
                    <measurement group_id="O2" value="5.8" spread="7.20"/>
                    <measurement group_id="O3" value="-2.9" spread="5.25"/>
                    <measurement group_id="O4" value="8.8" spread="13.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 167 (n=22, 32, 28, 26)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-18.0" spread="6.71"/>
                    <measurement group_id="O2" value="-0.1" spread="6.99"/>
                    <measurement group_id="O3" value="-14.6" spread="6.21"/>
                    <measurement group_id="O4" value="4.3" spread="8.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 180 (n=20, 27, 27, 25)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-11.1" spread="6.57"/>
                    <measurement group_id="O2" value="-24.0" spread="6.18"/>
                    <measurement group_id="O3" value="-17.3" spread="6.54"/>
                    <measurement group_id="O4" value="4.0" spread="10.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 193 (n=17, 25, 25, 22)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-13.6" spread="8.11"/>
                    <measurement group_id="O2" value="-13.4" spread="9.58"/>
                    <measurement group_id="O3" value="-13.4" spread="6.00"/>
                    <measurement group_id="O4" value="-12.0" spread="7.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 206 (n=15, 21, 23, 21)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.6" spread="10.45"/>
                    <measurement group_id="O2" value="-18.7" spread="9.01"/>
                    <measurement group_id="O3" value="6.2" spread="9.35"/>
                    <measurement group_id="O4" value="-6.1" spread="11.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Baseline and Changes From Baseline in White Blood Cell Counts (x 10^3 c/µL) During the ST + LT Period</title>
        <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
        <population>Treated participants; n=number of treated participants with measurement at time point</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg</title>
            <description>Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg</title>
            <description>Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
            <description>Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline and Changes From Baseline in White Blood Cell Counts (x 10^3 c/µL) During the ST + LT Period</title>
          <population>Treated participants; n=number of treated participants with measurement at time point</population>
          <units>x 10^3 c/µL</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="102"/>
                <count group_id="O2" value="106"/>
                <count group_id="O3" value="98"/>
                <count group_id="O4" value="95"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (BL) (Week 0) (n=102, 106, 98, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.71" spread="0.179"/>
                    <measurement group_id="O2" value="6.75" spread="0.198"/>
                    <measurement group_id="O3" value="6.82" spread="0.155"/>
                    <measurement group_id="O4" value="6.79" spread="0.182"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 2 (n=95, 99, 92, 86)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.11" spread="0.136"/>
                    <measurement group_id="O2" value="0.05" spread="0.132"/>
                    <measurement group_id="O3" value="-0.14" spread="0.113"/>
                    <measurement group_id="O4" value="-0.23" spread="0.156"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 4 (n=92, 99, 90, 90)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.06" spread="0.132"/>
                    <measurement group_id="O2" value="0.05" spread="0.125"/>
                    <measurement group_id="O3" value="-0.16" spread="0.132"/>
                    <measurement group_id="O4" value="0.17" spread="0.137"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 6 (n=89, 95, 87, 82)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.115"/>
                    <measurement group_id="O2" value="0.10" spread="0.126"/>
                    <measurement group_id="O3" value="-0.18" spread="0.128"/>
                    <measurement group_id="O4" value="0.09" spread="0.172"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 8 (n=91, 89, 90, 79)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.132"/>
                    <measurement group_id="O2" value="0.18" spread="0.144"/>
                    <measurement group_id="O3" value="-0.17" spread="0.121"/>
                    <measurement group_id="O4" value="0.16" spread="0.149"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 10 (n=68, 76, 69, 63)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.32" spread="0.168"/>
                    <measurement group_id="O2" value="0.55" spread="0.169"/>
                    <measurement group_id="O3" value="0.12" spread="0.162"/>
                    <measurement group_id="O4" value="0.53" spread="0.208"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 12 (n=83, 88, 87, 82)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.00" spread="0.148"/>
                    <measurement group_id="O2" value="0.09" spread="0.155"/>
                    <measurement group_id="O3" value="0.05" spread="0.145"/>
                    <measurement group_id="O4" value="0.26" spread="0.163"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 14 (n=76, 78, 80, 75)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.33" spread="0.196"/>
                    <measurement group_id="O2" value="0.71" spread="0.166"/>
                    <measurement group_id="O3" value="0.22" spread="0.134"/>
                    <measurement group_id="O4" value="0.56" spread="0.192"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 16 (n=90, 91, 83, 71)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.24" spread="0.146"/>
                    <measurement group_id="O2" value="0.54" spread="0.148"/>
                    <measurement group_id="O3" value="0.04" spread="0.138"/>
                    <measurement group_id="O4" value="0.19" spread="0.163"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 18 (n=78, 75, 82, 71)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.37" spread="0.166"/>
                    <measurement group_id="O2" value="0.82" spread="0.172"/>
                    <measurement group_id="O3" value="0.42" spread="0.142"/>
                    <measurement group_id="O4" value="0.32" spread="0.185"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 20 (n=83, 79, 78, 72)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.29" spread="0.150"/>
                    <measurement group_id="O2" value="0.29" spread="0.163"/>
                    <measurement group_id="O3" value="0.01" spread="0.140"/>
                    <measurement group_id="O4" value="0.02" spread="0.154"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 22 (n=77, 74, 76, 65)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.66" spread="0.184"/>
                    <measurement group_id="O2" value="0.72" spread="0.178"/>
                    <measurement group_id="O3" value="0.44" spread="0.175"/>
                    <measurement group_id="O4" value="0.45" spread="0.163"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 24 (n=83, 82, 78, 74)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.10" spread="0.149"/>
                    <measurement group_id="O2" value="0.47" spread="0.265"/>
                    <measurement group_id="O3" value="0.08" spread="0.158"/>
                    <measurement group_id="O4" value="-0.06" spread="0.142"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 30 (n=77, 78, 79, 67)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.15" spread="0.148"/>
                    <measurement group_id="O2" value="0.33" spread="0.202"/>
                    <measurement group_id="O3" value="0.28" spread="0.167"/>
                    <measurement group_id="O4" value="-0.03" spread="0.129"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 37 (n=74, 73, 70, 62)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.21" spread="0.163"/>
                    <measurement group_id="O2" value="0.42" spread="0.204"/>
                    <measurement group_id="O3" value="0.12" spread="0.189"/>
                    <measurement group_id="O4" value="0.14" spread="0.159"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 50 (n=67, 69, 71, 61)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.168"/>
                    <measurement group_id="O2" value="0.33" spread="0.216"/>
                    <measurement group_id="O3" value="-0.03" spread="0.149"/>
                    <measurement group_id="O4" value="0.29" spread="0.186"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 63 (n=60, 66, 67, 55)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.12" spread="0.176"/>
                    <measurement group_id="O2" value="0.20" spread="0.221"/>
                    <measurement group_id="O3" value="-0.04" spread="0.180"/>
                    <measurement group_id="O4" value="0.06" spread="0.176"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 76 (n=51, 58, 63, 49)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.185"/>
                    <measurement group_id="O2" value="0.23" spread="0.259"/>
                    <measurement group_id="O3" value="-0.07" spread="0.158"/>
                    <measurement group_id="O4" value="-0.20" spread="0.169"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 89 (n=48, 58, 56, 42)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.51" spread="0.232"/>
                    <measurement group_id="O2" value="0.17" spread="0.246"/>
                    <measurement group_id="O3" value="-0.10" spread="0.152"/>
                    <measurement group_id="O4" value="-0.18" spread="0.232"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 102 (n=39, 47, 51, 40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.16" spread="0.218"/>
                    <measurement group_id="O2" value="0.44" spread="0.258"/>
                    <measurement group_id="O3" value="0.10" spread="0.129"/>
                    <measurement group_id="O4" value="-0.09" spread="0.208"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 115 (n=34, 43, 42, 34)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.24" spread="0.235"/>
                    <measurement group_id="O2" value="0.93" spread="0.252"/>
                    <measurement group_id="O3" value="0.11" spread="0.210"/>
                    <measurement group_id="O4" value="0.44" spread="0.286"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 128 (n=30, 40, 40, 29)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.58" spread="0.227"/>
                    <measurement group_id="O2" value="0.66" spread="0.314"/>
                    <measurement group_id="O3" value="0.44" spread="0.221"/>
                    <measurement group_id="O4" value="0.22" spread="0.286"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 141 (n=28, 39, 34, 28)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.35" spread="0.183"/>
                    <measurement group_id="O2" value="0.78" spread="0.303"/>
                    <measurement group_id="O3" value="0.44" spread="0.199"/>
                    <measurement group_id="O4" value="0.51" spread="0.214"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 154 (n=26, 34, 31, 24)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.12" spread="0.228"/>
                    <measurement group_id="O2" value="0.44" spread="0.327"/>
                    <measurement group_id="O3" value="0.30" spread="0.212"/>
                    <measurement group_id="O4" value="0.38" spread="0.217"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 167 (n=24, 33, 30, 25)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.22" spread="0.233"/>
                    <measurement group_id="O2" value="0.44" spread="0.341"/>
                    <measurement group_id="O3" value="0.27" spread="0.209"/>
                    <measurement group_id="O4" value="0.35" spread="0.180"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 180 (n=21, 28, 28, 26)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.13" spread="0.233"/>
                    <measurement group_id="O2" value="0.30" spread="0.379"/>
                    <measurement group_id="O3" value="0.59" spread="0.263"/>
                    <measurement group_id="O4" value="0.65" spread="0.267"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 193 (n=19, 26, 26, 23)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.34" spread="0.220"/>
                    <measurement group_id="O2" value="0.02" spread="0.403"/>
                    <measurement group_id="O3" value="0.60" spread="0.205"/>
                    <measurement group_id="O4" value="0.19" spread="0.157"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 206 (n=17, 22, 23, 21)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.199"/>
                    <measurement group_id="O2" value="0.55" spread="0.420"/>
                    <measurement group_id="O3" value="1.01" spread="0.303"/>
                    <measurement group_id="O4" value="0.38" spread="0.284"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Baseline and Changes From Baseline in Absolute Neutrophil Counts (x 10^3 c/µL) During the ST + LT Period</title>
        <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
        <population>Treated participants; n=number of treated participants with measurement at time point</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg</title>
            <description>Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg</title>
            <description>Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
            <description>Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline and Changes From Baseline in Absolute Neutrophil Counts (x 10^3 c/µL) During the ST + LT Period</title>
          <population>Treated participants; n=number of treated participants with measurement at time point</population>
          <units>x 10^3 c/µL</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="102"/>
                <count group_id="O2" value="106"/>
                <count group_id="O3" value="98"/>
                <count group_id="O4" value="95"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (BL) (Week 0) (n=102, 106, 98, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.00" spread="0.141"/>
                    <measurement group_id="O2" value="3.98" spread="0.142"/>
                    <measurement group_id="O3" value="4.16" spread="0.137"/>
                    <measurement group_id="O4" value="4.01" spread="0.148"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 2 (n=95, 99, 92, 86)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.06" spread="0.122"/>
                    <measurement group_id="O2" value="0.11" spread="0.117"/>
                    <measurement group_id="O3" value="0.00" spread="0.101"/>
                    <measurement group_id="O4" value="-0.07" spread="0.131"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 4 (n=91, 99, 90, 90)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.09" spread="0.114"/>
                    <measurement group_id="O2" value="0.16" spread="0.103"/>
                    <measurement group_id="O3" value="0.05" spread="0.121"/>
                    <measurement group_id="O4" value="0.23" spread="0.120"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 6 (n=89, 95, 87, 82)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.105"/>
                    <measurement group_id="O2" value="0.19" spread="0.097"/>
                    <measurement group_id="O3" value="0.04" spread="0.114"/>
                    <measurement group_id="O4" value="0.17" spread="0.150"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 8 (n=91, 88, 90, 79)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.110"/>
                    <measurement group_id="O2" value="0.27" spread="0.131"/>
                    <measurement group_id="O3" value="0.03" spread="0.096"/>
                    <measurement group_id="O4" value="0.19" spread="0.126"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 10 (n=68, 76, 69, 63)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.18" spread="0.135"/>
                    <measurement group_id="O2" value="0.48" spread="0.145"/>
                    <measurement group_id="O3" value="0.17" spread="0.139"/>
                    <measurement group_id="O4" value="0.45" spread="0.169"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 12 (n=83, 88, 87, 82)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.135"/>
                    <measurement group_id="O2" value="0.21" spread="0.130"/>
                    <measurement group_id="O3" value="0.18" spread="0.115"/>
                    <measurement group_id="O4" value="0.30" spread="0.139"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 14 (n=76, 77, 80, 75)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.07" spread="0.158"/>
                    <measurement group_id="O2" value="0.64" spread="0.119"/>
                    <measurement group_id="O3" value="0.17" spread="0.115"/>
                    <measurement group_id="O4" value="0.46" spread="0.161"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 16 (n=90, 91, 83, 71)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.17" spread="0.116"/>
                    <measurement group_id="O2" value="0.49" spread="0.132"/>
                    <measurement group_id="O3" value="0.16" spread="0.132"/>
                    <measurement group_id="O4" value="0.18" spread="0.140"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 18 (n=78, 75, 82, 71)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.23" spread="0.120"/>
                    <measurement group_id="O2" value="0.67" spread="0.149"/>
                    <measurement group_id="O3" value="0.32" spread="0.130"/>
                    <measurement group_id="O4" value="0.21" spread="0.148"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 20 (n=83, 79, 78, 72)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.19" spread="0.131"/>
                    <measurement group_id="O2" value="0.32" spread="0.141"/>
                    <measurement group_id="O3" value="0.07" spread="0.130"/>
                    <measurement group_id="O4" value="0.15" spread="0.127"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 22 (n=77, 74, 75, 65)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.44" spread="0.155"/>
                    <measurement group_id="O2" value="0.58" spread="0.160"/>
                    <measurement group_id="O3" value="0.44" spread="0.153"/>
                    <measurement group_id="O4" value="0.32" spread="0.130"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 24 (n=83, 81, 78, 74)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.09" spread="0.124"/>
                    <measurement group_id="O2" value="0.57" spread="0.263"/>
                    <measurement group_id="O3" value="0.16" spread="0.130"/>
                    <measurement group_id="O4" value="-0.03" spread="0.115"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 30 (n=76, 78, 79, 67)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" spread="0.124"/>
                    <measurement group_id="O2" value="0.29" spread="0.155"/>
                    <measurement group_id="O3" value="0.32" spread="0.122"/>
                    <measurement group_id="O4" value="0.00" spread="0.114"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 37 (n=74, 72, 70, 60)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.13" spread="0.146"/>
                    <measurement group_id="O2" value="0.42" spread="0.171"/>
                    <measurement group_id="O3" value="0.24" spread="0.165"/>
                    <measurement group_id="O4" value="0.20" spread="0.137"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 50 (n=67, 69, 71, 61)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.144"/>
                    <measurement group_id="O2" value="0.40" spread="0.182"/>
                    <measurement group_id="O3" value="0.19" spread="0.128"/>
                    <measurement group_id="O4" value="0.27" spread="0.161"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 63 (n=60, 66, 67, 55)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.11" spread="0.140"/>
                    <measurement group_id="O2" value="0.25" spread="0.176"/>
                    <measurement group_id="O3" value="0.08" spread="0.168"/>
                    <measurement group_id="O4" value="0.16" spread="0.152"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 76 (n=51, 58, 63, 49)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.161"/>
                    <measurement group_id="O2" value="0.33" spread="0.204"/>
                    <measurement group_id="O3" value="0.08" spread="0.146"/>
                    <measurement group_id="O4" value="-0.01" spread="0.140"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 89 (n=48, 58, 56, 42)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.58" spread="0.208"/>
                    <measurement group_id="O2" value="0.18" spread="0.178"/>
                    <measurement group_id="O3" value="0.05" spread="0.136"/>
                    <measurement group_id="O4" value="0.01" spread="0.185"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 102 (n=39, 47, 50, 40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.19" spread="0.212"/>
                    <measurement group_id="O2" value="0.43" spread="0.215"/>
                    <measurement group_id="O3" value="0.24" spread="0.114"/>
                    <measurement group_id="O4" value="0.01" spread="0.176"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 115 (n=34, 43, 42, 34)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.28" spread="0.219"/>
                    <measurement group_id="O2" value="0.81" spread="0.165"/>
                    <measurement group_id="O3" value="0.29" spread="0.178"/>
                    <measurement group_id="O4" value="0.42" spread="0.223"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 128 (n=30, 40, 40, 29)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.61" spread="0.202"/>
                    <measurement group_id="O2" value="0.59" spread="0.244"/>
                    <measurement group_id="O3" value="0.56" spread="0.209"/>
                    <measurement group_id="O4" value="0.22" spread="0.245"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 141 (n=28, 38, 34, 28)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.41" spread="0.168"/>
                    <measurement group_id="O2" value="0.80" spread="0.254"/>
                    <measurement group_id="O3" value="0.45" spread="0.161"/>
                    <measurement group_id="O4" value="0.40" spread="0.198"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 154 (n=26, 33, 31, 24)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.25" spread="0.223"/>
                    <measurement group_id="O2" value="0.39" spread="0.225"/>
                    <measurement group_id="O3" value="0.47" spread="0.162"/>
                    <measurement group_id="O4" value="0.41" spread="0.184"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 167 (n=24, 33, 30, 25)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.04" spread="0.211"/>
                    <measurement group_id="O2" value="0.56" spread="0.239"/>
                    <measurement group_id="O3" value="0.27" spread="0.193"/>
                    <measurement group_id="O4" value="0.33" spread="0.176"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 180 (n=21, 28, 28, 26)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.23" spread="0.220"/>
                    <measurement group_id="O2" value="0.50" spread="0.293"/>
                    <measurement group_id="O3" value="0.55" spread="0.200"/>
                    <measurement group_id="O4" value="0.51" spread="0.271"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 193 (n=19, 25, 26, 23)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.34" spread="0.181"/>
                    <measurement group_id="O2" value="0.08" spread="0.277"/>
                    <measurement group_id="O3" value="0.51" spread="0.166"/>
                    <measurement group_id="O4" value="-0.01" spread="0.130"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 206 (n=17, 22, 23, 21)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.15" spread="0.218"/>
                    <measurement group_id="O2" value="0.63" spread="0.389"/>
                    <measurement group_id="O3" value="0.90" spread="0.284"/>
                    <measurement group_id="O4" value="0.31" spread="0.235"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Baseline and Changes From Baseline in Absolute Lymphocyte Counts (x 10^3 c/µL) During the ST + LT Period</title>
        <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
        <population>Treated participants; n=number of treated participants with measurement at time point</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg</title>
            <description>Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg</title>
            <description>Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
            <description>Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline and Changes From Baseline in Absolute Lymphocyte Counts (x 10^3 c/µL) During the ST + LT Period</title>
          <population>Treated participants; n=number of treated participants with measurement at time point</population>
          <units>x 10^3 c/µL</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="102"/>
                <count group_id="O2" value="106"/>
                <count group_id="O3" value="98"/>
                <count group_id="O4" value="95"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (BL) (Week 0) (n=102, 106, 98, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.16" spread="0.062"/>
                    <measurement group_id="O2" value="2.21" spread="0.071"/>
                    <measurement group_id="O3" value="2.14" spread="0.063"/>
                    <measurement group_id="O4" value="2.22" spread="0.063"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 2 (n=95, 99, 92, 86)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.04" spread="0.052"/>
                    <measurement group_id="O2" value="-0.10" spread="0.045"/>
                    <measurement group_id="O3" value="-0.11" spread="0.046"/>
                    <measurement group_id="O4" value="-0.13" spread="0.049"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 4 (n=91, 99, 90, 90)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.03" spread="0.056"/>
                    <measurement group_id="O2" value="-0.12" spread="0.046"/>
                    <measurement group_id="O3" value="-0.18" spread="0.046"/>
                    <measurement group_id="O4" value="-0.04" spread="0.040"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 6 (n=89, 95, 87, 82)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.04" spread="0.049"/>
                    <measurement group_id="O2" value="-0.09" spread="0.057"/>
                    <measurement group_id="O3" value="-0.23" spread="0.047"/>
                    <measurement group_id="O4" value="-0.09" spread="0.048"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 8 (n=91, 88, 90, 79)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.07" spread="0.049"/>
                    <measurement group_id="O2" value="-0.11" spread="0.049"/>
                    <measurement group_id="O3" value="-0.20" spread="0.048"/>
                    <measurement group_id="O4" value="-0.00" spread="0.053"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 10 (n=68, 76, 69, 63)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.07" spread="0.069"/>
                    <measurement group_id="O2" value="0.02" spread="0.055"/>
                    <measurement group_id="O3" value="-0.10" spread="0.053"/>
                    <measurement group_id="O4" value="0.05" spread="0.068"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 12 (n=83, 88, 87, 82)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.06" spread="0.049"/>
                    <measurement group_id="O2" value="-0.12" spread="0.044"/>
                    <measurement group_id="O3" value="-0.16" spread="0.052"/>
                    <measurement group_id="O4" value="-0.02" spread="0.058"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 14 (n=76, 77, 80, 75)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.20" spread="0.071"/>
                    <measurement group_id="O2" value="0.08" spread="0.085"/>
                    <measurement group_id="O3" value="-0.01" spread="0.052"/>
                    <measurement group_id="O4" value="0.06" spread="0.058"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 16 (n=90, 91, 83, 71)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.065"/>
                    <measurement group_id="O2" value="0.01" spread="0.057"/>
                    <measurement group_id="O3" value="-0.11" spread="0.049"/>
                    <measurement group_id="O4" value="0.01" spread="0.061"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 18 (n=78, 75, 82, 71)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.11" spread="0.079"/>
                    <measurement group_id="O2" value="0.13" spread="0.064"/>
                    <measurement group_id="O3" value="0.01" spread="0.064"/>
                    <measurement group_id="O4" value="0.08" spread="0.069"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 20 (n=83, 79, 78, 72)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.08" spread="0.065"/>
                    <measurement group_id="O2" value="-0.02" spread="0.064"/>
                    <measurement group_id="O3" value="-0.10" spread="0.058"/>
                    <measurement group_id="O4" value="-0.11" spread="0.052"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 22 (n=77, 74, 75, 65)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.16" spread="0.069"/>
                    <measurement group_id="O2" value="0.13" spread="0.083"/>
                    <measurement group_id="O3" value="-0.07" spread="0.060"/>
                    <measurement group_id="O4" value="0.09" spread="0.067"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 24 (n=83, 81, 78, 74)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.00" spread="0.068"/>
                    <measurement group_id="O2" value="-0.07" spread="0.071"/>
                    <measurement group_id="O3" value="-0.13" spread="0.054"/>
                    <measurement group_id="O4" value="-0.01" spread="0.059"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 30 (n=76, 78, 79, 67)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.08" spread="0.066"/>
                    <measurement group_id="O2" value="-0.00" spread="0.060"/>
                    <measurement group_id="O3" value="-0.09" spread="0.063"/>
                    <measurement group_id="O4" value="-0.03" spread="0.059"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 37 (n=74, 72, 70, 60)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.067"/>
                    <measurement group_id="O2" value="0.02" spread="0.064"/>
                    <measurement group_id="O3" value="-0.17" spread="0.056"/>
                    <measurement group_id="O4" value="-0.08" spread="0.066"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 50 (n=67, 69, 71, 61)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.06" spread="0.071"/>
                    <measurement group_id="O2" value="-0.09" spread="0.069"/>
                    <measurement group_id="O3" value="-0.25" spread="0.051"/>
                    <measurement group_id="O4" value="-0.03" spread="0.059"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 63 (n=60, 66, 67, 55)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.06" spread="0.077"/>
                    <measurement group_id="O2" value="-0.10" spread="0.063"/>
                    <measurement group_id="O3" value="-0.19" spread="0.070"/>
                    <measurement group_id="O4" value="-0.16" spread="0.063"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 76 (n=51, 58, 63, 49)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.10" spread="0.086"/>
                    <measurement group_id="O2" value="-0.09" spread="0.082"/>
                    <measurement group_id="O3" value="-0.18" spread="0.054"/>
                    <measurement group_id="O4" value="-0.20" spread="0.072"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 89 (n=49, 58, 56, 42)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.12" spread="0.087"/>
                    <measurement group_id="O2" value="-0.02" spread="0.080"/>
                    <measurement group_id="O3" value="-0.19" spread="0.054"/>
                    <measurement group_id="O4" value="-0.23" spread="0.083"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 102 (n=39, 48, 51, 40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.17" spread="0.081"/>
                    <measurement group_id="O2" value="-0.07" spread="0.086"/>
                    <measurement group_id="O3" value="-0.23" spread="0.056"/>
                    <measurement group_id="O4" value="-0.16" spread="0.071"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 115 (n=34, 43, 43, 35)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.15" spread="0.080"/>
                    <measurement group_id="O2" value="-0.00" spread="0.103"/>
                    <measurement group_id="O3" value="-0.21" spread="0.068"/>
                    <measurement group_id="O4" value="-0.10" spread="0.100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 128 (n=30, 40, 40, 30)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.12" spread="0.106"/>
                    <measurement group_id="O2" value="-0.00" spread="0.105"/>
                    <measurement group_id="O3" value="-0.16" spread="0.068"/>
                    <measurement group_id="O4" value="-0.06" spread="0.094"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 141 (n=28, 38, 34, 28)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.13" spread="0.089"/>
                    <measurement group_id="O2" value="-0.03" spread="0.083"/>
                    <measurement group_id="O3" value="-0.10" spread="0.079"/>
                    <measurement group_id="O4" value="0.00" spread="0.086"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 154 (n=26, 33, 31, 24)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.23" spread="0.096"/>
                    <measurement group_id="O2" value="0.04" spread="0.128"/>
                    <measurement group_id="O3" value="-0.23" spread="0.101"/>
                    <measurement group_id="O4" value="-0.14" spread="0.096"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 167 (n=24, 33, 30, 25)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.23" spread="0.096"/>
                    <measurement group_id="O2" value="-0.13" spread="0.118"/>
                    <measurement group_id="O3" value="-0.11" spread="0.090"/>
                    <measurement group_id="O4" value="-0.16" spread="0.084"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 180 (n=21, 28, 28, 26)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.15" spread="0.107"/>
                    <measurement group_id="O2" value="-0.22" spread="0.130"/>
                    <measurement group_id="O3" value="-0.06" spread="0.105"/>
                    <measurement group_id="O4" value="-0.05" spread="0.102"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 193 (n=19, 25, 26, 23)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.06" spread="0.094"/>
                    <measurement group_id="O2" value="-0.09" spread="0.151"/>
                    <measurement group_id="O3" value="-0.04" spread="0.092"/>
                    <measurement group_id="O4" value="0.01" spread="0.101"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 206 (n=17, 22, 23, 21)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.17" spread="0.126"/>
                    <measurement group_id="O2" value="-0.14" spread="0.105"/>
                    <measurement group_id="O3" value="-0.05" spread="0.094"/>
                    <measurement group_id="O4" value="-0.08" spread="0.113"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Baseline and Changes From Baseline in Absolute Monocyte Counts (x 10^3 c/µL) During the ST + LT Period</title>
        <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
        <population>Treated participants; n=number of treated participants with measurement at time point</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg</title>
            <description>Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg</title>
            <description>Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
            <description>Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline and Changes From Baseline in Absolute Monocyte Counts (x 10^3 c/µL) During the ST + LT Period</title>
          <population>Treated participants; n=number of treated participants with measurement at time point</population>
          <units>x 10^3 c/µL</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="102"/>
                <count group_id="O2" value="106"/>
                <count group_id="O3" value="98"/>
                <count group_id="O4" value="95"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (BL) (Week 0) (n=102, 106, 98, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.31" spread="0.016"/>
                    <measurement group_id="O2" value="0.34" spread="0.017"/>
                    <measurement group_id="O3" value="0.32" spread="0.016"/>
                    <measurement group_id="O4" value="0.32" spread="0.015"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 2 (n=95, 99, 92, 86)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.015"/>
                    <measurement group_id="O2" value="0.01" spread="0.017"/>
                    <measurement group_id="O3" value="-0.05" spread="0.021"/>
                    <measurement group_id="O4" value="-0.01" spread="0.018"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 4 (n=91, 99, 90, 90)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.015"/>
                    <measurement group_id="O2" value="0.00" spread="0.014"/>
                    <measurement group_id="O3" value="-0.01" spread="0.020"/>
                    <measurement group_id="O4" value="0.01" spread="0.015"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 6 (n=89, 95, 87, 82)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.017"/>
                    <measurement group_id="O2" value="-0.01" spread="0.017"/>
                    <measurement group_id="O3" value="-0.01" spread="0.019"/>
                    <measurement group_id="O4" value="0.02" spread="0.019"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 8 (n=91, 88, 90, 79)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.016"/>
                    <measurement group_id="O2" value="0.03" spread="0.018"/>
                    <measurement group_id="O3" value="-0.01" spread="0.017"/>
                    <measurement group_id="O4" value="-0.02" spread="0.018"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 10 (n=68, 76, 69, 63)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.08" spread="0.020"/>
                    <measurement group_id="O2" value="0.04" spread="0.021"/>
                    <measurement group_id="O3" value="0.04" spread="0.021"/>
                    <measurement group_id="O4" value="0.03" spread="0.024"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 12 (n=83, 88, 87, 82)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.017"/>
                    <measurement group_id="O2" value="0.00" spread="0.018"/>
                    <measurement group_id="O3" value="0.00" spread="0.019"/>
                    <measurement group_id="O4" value="0.01" spread="0.018"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 14 (n=76, 77, 80, 75)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.09" spread="0.019"/>
                    <measurement group_id="O2" value="0.06" spread="0.022"/>
                    <measurement group_id="O3" value="0.03" spread="0.021"/>
                    <measurement group_id="O4" value="0.04" spread="0.021"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 16 (n=90, 91, 83, 71)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.06" spread="0.018"/>
                    <measurement group_id="O2" value="0.04" spread="0.019"/>
                    <measurement group_id="O3" value="0.04" spread="0.019"/>
                    <measurement group_id="O4" value="0.01" spread="0.017"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 18 (n=78, 75, 82, 71)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.06" spread="0.018"/>
                    <measurement group_id="O2" value="0.05" spread="0.025"/>
                    <measurement group_id="O3" value="0.06" spread="0.018"/>
                    <measurement group_id="O4" value="0.04" spread="0.021"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 20 (n=83, 79, 78, 72)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" spread="0.017"/>
                    <measurement group_id="O2" value="0.02" spread="0.018"/>
                    <measurement group_id="O3" value="0.04" spread="0.021"/>
                    <measurement group_id="O4" value="0.01" spread="0.022"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 22 (n=77, 74, 75, 65)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.08" spread="0.023"/>
                    <measurement group_id="O2" value="0.05" spread="0.017"/>
                    <measurement group_id="O3" value="0.06" spread="0.021"/>
                    <measurement group_id="O4" value="0.05" spread="0.021"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 24 (n=83, 81, 78, 74)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" spread="0.019"/>
                    <measurement group_id="O2" value="0.01" spread="0.019"/>
                    <measurement group_id="O3" value="0.03" spread="0.019"/>
                    <measurement group_id="O4" value="0.03" spread="0.019"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 30 (n=76, 78, 79, 67)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.020"/>
                    <measurement group_id="O2" value="0.03" spread="0.022"/>
                    <measurement group_id="O3" value="0.04" spread="0.021"/>
                    <measurement group_id="O4" value="0.03" spread="0.018"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 37 (n=74, 72, 70, 60)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.06" spread="0.022"/>
                    <measurement group_id="O2" value="0.02" spread="0.022"/>
                    <measurement group_id="O3" value="0.04" spread="0.020"/>
                    <measurement group_id="O4" value="0.00" spread="0.020"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 50 (n=67, 69, 71, 61)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.07" spread="0.021"/>
                    <measurement group_id="O2" value="0.03" spread="0.020"/>
                    <measurement group_id="O3" value="0.05" spread="0.022"/>
                    <measurement group_id="O4" value="0.06" spread="0.018"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 63 (n=60, 66, 67, 55)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.08" spread="0.021"/>
                    <measurement group_id="O2" value="0.05" spread="0.022"/>
                    <measurement group_id="O3" value="0.07" spread="0.026"/>
                    <measurement group_id="O4" value="0.07" spread="0.019"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 76 (n=51, 58, 63, 49)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.12" spread="0.026"/>
                    <measurement group_id="O2" value="0.04" spread="0.028"/>
                    <measurement group_id="O3" value="0.06" spread="0.024"/>
                    <measurement group_id="O4" value="0.05" spread="0.020"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 89 (n=48, 58, 56, 42)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.11" spread="0.023"/>
                    <measurement group_id="O2" value="0.03" spread="0.026"/>
                    <measurement group_id="O3" value="0.08" spread="0.022"/>
                    <measurement group_id="O4" value="0.05" spread="0.028"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 102 (n=39, 47, 50, 40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.14" spread="0.025"/>
                    <measurement group_id="O2" value="0.04" spread="0.028"/>
                    <measurement group_id="O3" value="0.09" spread="0.028"/>
                    <measurement group_id="O4" value="0.07" spread="0.025"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 115 (n=34, 43, 42, 34)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.12" spread="0.033"/>
                    <measurement group_id="O2" value="0.05" spread="0.026"/>
                    <measurement group_id="O3" value="0.06" spread="0.029"/>
                    <measurement group_id="O4" value="0.13" spread="0.030"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 128 (n=30, 40, 40, 29)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.12" spread="0.031"/>
                    <measurement group_id="O2" value="0.04" spread="0.031"/>
                    <measurement group_id="O3" value="0.07" spread="0.026"/>
                    <measurement group_id="O4" value="0.07" spread="0.022"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 141 (n=28, 38, 34, 28)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.08" spread="0.029"/>
                    <measurement group_id="O2" value="0.02" spread="0.030"/>
                    <measurement group_id="O3" value="0.10" spread="0.028"/>
                    <measurement group_id="O4" value="0.10" spread="0.024"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 154 (n=26, 33, 31, 24)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.10" spread="0.025"/>
                    <measurement group_id="O2" value="0.05" spread="0.037"/>
                    <measurement group_id="O3" value="0.06" spread="0.035"/>
                    <measurement group_id="O4" value="0.08" spread="0.022"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 167 (n=24, 33, 30, 25)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.07" spread="0.029"/>
                    <measurement group_id="O2" value="0.04" spread="0.036"/>
                    <measurement group_id="O3" value="0.10" spread="0.036"/>
                    <measurement group_id="O4" value="0.11" spread="0.023"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 180 (n=21, 28, 28, 26)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.08" spread="0.028"/>
                    <measurement group_id="O2" value="0.04" spread="0.041"/>
                    <measurement group_id="O3" value="0.11" spread="0.040"/>
                    <measurement group_id="O4" value="0.11" spread="0.021"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 193 (n=19, 25, 26, 23)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.09" spread="0.039"/>
                    <measurement group_id="O2" value="0.04" spread="0.044"/>
                    <measurement group_id="O3" value="0.11" spread="0.036"/>
                    <measurement group_id="O4" value="0.13" spread="0.023"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 206 (n=17, 22, 23, 21)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.033"/>
                    <measurement group_id="O2" value="0.05" spread="0.034"/>
                    <measurement group_id="O3" value="0.13" spread="0.042"/>
                    <measurement group_id="O4" value="0.09" spread="0.023"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Baseline and Changes From Baseline in Absolute Basophil Counts (x 10^3 c/µL) During the ST + LT Period</title>
        <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
        <population>Treated participants; n=number of treated participants with measurement at time point</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg</title>
            <description>Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg</title>
            <description>Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
            <description>Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline and Changes From Baseline in Absolute Basophil Counts (x 10^3 c/µL) During the ST + LT Period</title>
          <population>Treated participants; n=number of treated participants with measurement at time point</population>
          <units>x 10^3 c/µL</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="102"/>
                <count group_id="O2" value="106"/>
                <count group_id="O3" value="98"/>
                <count group_id="O4" value="95"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (BL) (Week 0) (n=102, 106, 98, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.003"/>
                    <measurement group_id="O2" value="0.02" spread="0.004"/>
                    <measurement group_id="O3" value="0.02" spread="0.004"/>
                    <measurement group_id="O4" value="0.02" spread="0.004"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 2 (n=95, 99, 92, 86)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.004"/>
                    <measurement group_id="O2" value="-0.01" spread="0.004"/>
                    <measurement group_id="O3" value="-0.01" spread="0.004"/>
                    <measurement group_id="O4" value="0.00" spread="0.005"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 4 (n=91, 99, 90, 90)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.004"/>
                    <measurement group_id="O2" value="-0.01" spread="0.004"/>
                    <measurement group_id="O3" value="-0.01" spread="0.003"/>
                    <measurement group_id="O4" value="-0.00" spread="0.005"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 6 (n=89, 95, 87, 82)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.005"/>
                    <measurement group_id="O2" value="-0.01" spread="0.004"/>
                    <measurement group_id="O3" value="-0.01" spread="0.004"/>
                    <measurement group_id="O4" value="-0.01" spread="0.005"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 8 (n=91, 88, 90, 79)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.003"/>
                    <measurement group_id="O2" value="-0.00" spread="0.005"/>
                    <measurement group_id="O3" value="-0.01" spread="0.004"/>
                    <measurement group_id="O4" value="-0.01" spread="0.005"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 10 (n=68, 76, 69, 63)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.004"/>
                    <measurement group_id="O2" value="-0.01" spread="0.004"/>
                    <measurement group_id="O3" value="-0.01" spread="0.004"/>
                    <measurement group_id="O4" value="-0.01" spread="0.005"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 12 (n=83, 88, 87, 82)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.00" spread="0.004"/>
                    <measurement group_id="O2" value="-0.01" spread="0.005"/>
                    <measurement group_id="O3" value="-0.00" spread="0.004"/>
                    <measurement group_id="O4" value="-0.00" spread="0.005"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 14 (n=76, 77, 80, 75)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.004"/>
                    <measurement group_id="O2" value="0.00" spread="0.006"/>
                    <measurement group_id="O3" value="-0.01" spread="0.004"/>
                    <measurement group_id="O4" value="-0.00" spread="0.005"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 16 (n=90, 91, 83, 71)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.004"/>
                    <measurement group_id="O2" value="-0.00" spread="0.005"/>
                    <measurement group_id="O3" value="-0.01" spread="0.003"/>
                    <measurement group_id="O4" value="-0.01" spread="0.006"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 18 (n=78, 75, 82, 71)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.004"/>
                    <measurement group_id="O2" value="0.00" spread="0.005"/>
                    <measurement group_id="O3" value="-0.00" spread="0.006"/>
                    <measurement group_id="O4" value="-0.01" spread="0.005"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 20 (n=83, 79, 78, 72)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.004"/>
                    <measurement group_id="O2" value="-0.01" spread="0.005"/>
                    <measurement group_id="O3" value="-0.01" spread="0.004"/>
                    <measurement group_id="O4" value="-0.00" spread="0.005"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 22 (n=77, 74, 75, 65)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.004"/>
                    <measurement group_id="O2" value="-0.00" spread="0.005"/>
                    <measurement group_id="O3" value="0.00" spread="0.013"/>
                    <measurement group_id="O4" value="-0.00" spread="0.006"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 24 (n=83, 81, 78, 74)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.005"/>
                    <measurement group_id="O2" value="-0.01" spread="0.004"/>
                    <measurement group_id="O3" value="-0.01" spread="0.005"/>
                    <measurement group_id="O4" value="-0.01" spread="0.006"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 30 (n=76, 78, 79, 67)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.004"/>
                    <measurement group_id="O2" value="0.01" spread="0.006"/>
                    <measurement group_id="O3" value="-0.01" spread="0.005"/>
                    <measurement group_id="O4" value="0.01" spread="0.006"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 37 (n=74, 72, 70, 60)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.004"/>
                    <measurement group_id="O2" value="0.01" spread="0.006"/>
                    <measurement group_id="O3" value="0.00" spread="0.005"/>
                    <measurement group_id="O4" value="0.00" spread="0.007"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 50 (n=67, 69, 71, 61)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.004"/>
                    <measurement group_id="O2" value="0.01" spread="0.006"/>
                    <measurement group_id="O3" value="0.01" spread="0.005"/>
                    <measurement group_id="O4" value="0.02" spread="0.005"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 63 (n=60, 66, 67, 55)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.005"/>
                    <measurement group_id="O2" value="0.01" spread="0.005"/>
                    <measurement group_id="O3" value="0.02" spread="0.006"/>
                    <measurement group_id="O4" value="0.02" spread="0.004"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 76 (n=51, 58, 63, 49)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.004"/>
                    <measurement group_id="O2" value="0.01" spread="0.005"/>
                    <measurement group_id="O3" value="0.02" spread="0.005"/>
                    <measurement group_id="O4" value="0.01" spread="0.005"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 89 (n=48, 58, 56, 42)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.006"/>
                    <measurement group_id="O2" value="0.02" spread="0.006"/>
                    <measurement group_id="O3" value="0.02" spread="0.005"/>
                    <measurement group_id="O4" value="0.02" spread="0.006"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 102 (n=39, 47, 50, 40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.007"/>
                    <measurement group_id="O2" value="0.02" spread="0.005"/>
                    <measurement group_id="O3" value="0.02" spread="0.005"/>
                    <measurement group_id="O4" value="0.02" spread="0.007"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 115 (n=34, 43, 42, 34)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.006"/>
                    <measurement group_id="O2" value="0.03" spread="0.007"/>
                    <measurement group_id="O3" value="0.01" spread="0.007"/>
                    <measurement group_id="O4" value="0.03" spread="0.008"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 128 (n=30, 40, 40, 29)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.008"/>
                    <measurement group_id="O2" value="0.03" spread="0.007"/>
                    <measurement group_id="O3" value="0.01" spread="0.006"/>
                    <measurement group_id="O4" value="0.03" spread="0.008"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 141 (n=28, 38, 34, 28)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.008"/>
                    <measurement group_id="O2" value="0.02" spread="0.007"/>
                    <measurement group_id="O3" value="0.01" spread="0.007"/>
                    <measurement group_id="O4" value="0.02" spread="0.009"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 154 (n=26, 33, 31, 24)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.008"/>
                    <measurement group_id="O2" value="0.02" spread="0.006"/>
                    <measurement group_id="O3" value="0.02" spread="0.009"/>
                    <measurement group_id="O4" value="0.01" spread="0.010"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 167 (n=24, 33, 30, 25)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.009"/>
                    <measurement group_id="O2" value="0.01" spread="0.008"/>
                    <measurement group_id="O3" value="0.01" spread="0.008"/>
                    <measurement group_id="O4" value="0.02" spread="0.008"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 180 (n=21, 28, 28, 26)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.007"/>
                    <measurement group_id="O2" value="0.02" spread="0.007"/>
                    <measurement group_id="O3" value="0.00" spread="0.007"/>
                    <measurement group_id="O4" value="0.02" spread="0.009"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 193 (n=19, 25, 26, 23)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.010"/>
                    <measurement group_id="O2" value="0.01" spread="0.009"/>
                    <measurement group_id="O3" value="0.01" spread="0.008"/>
                    <measurement group_id="O4" value="0.02" spread="0.008"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 206 (n=17, 22, 23, 21)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.013"/>
                    <measurement group_id="O2" value="0.02" spread="0.010"/>
                    <measurement group_id="O3" value="0.01" spread="0.010"/>
                    <measurement group_id="O4" value="0.01" spread="0.009"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Baseline and Changes From Baseline in Absolute Eosinophil Counts (x 10^3 c/µL) During the ST + LT Period</title>
        <time_frame>Weeks 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
        <population>Treated participants; n=number of treated participants with measurement at time point</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg</title>
            <description>Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg</title>
            <description>Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
            <description>Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline and Changes From Baseline in Absolute Eosinophil Counts (x 10^3 c/µL) During the ST + LT Period</title>
          <population>Treated participants; n=number of treated participants with measurement at time point</population>
          <units>x 10^3 c/µL</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="102"/>
                <count group_id="O2" value="106"/>
                <count group_id="O3" value="98"/>
                <count group_id="O4" value="95"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (BL) (Week 0) (n=102, 106, 98, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.18" spread="0.012"/>
                    <measurement group_id="O2" value="0.20" spread="0.015"/>
                    <measurement group_id="O3" value="0.20" spread="0.012"/>
                    <measurement group_id="O4" value="0.20" spread="0.016"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 2 (n=95, 99, 92, 86)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.01" spread="0.008"/>
                    <measurement group_id="O2" value="0.01" spread="0.011"/>
                    <measurement group_id="O3" value="-0.02" spread="0.009"/>
                    <measurement group_id="O4" value="-0.02" spread="0.013"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 4 (n=91, 99, 90, 90)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.011"/>
                    <measurement group_id="O2" value="-0.01" spread="0.012"/>
                    <measurement group_id="O3" value="-0.01" spread="0.011"/>
                    <measurement group_id="O4" value="-0.02" spread="0.012"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 6 (n=89, 95, 87, 82)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.009"/>
                    <measurement group_id="O2" value="-0.01" spread="0.012"/>
                    <measurement group_id="O3" value="-0.02" spread="0.011"/>
                    <measurement group_id="O4" value="-0.02" spread="0.014"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 8 (n=91, 88, 90, 79)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.011"/>
                    <measurement group_id="O2" value="-0.01" spread="0.014"/>
                    <measurement group_id="O3" value="-0.02" spread="0.012"/>
                    <measurement group_id="O4" value="-0.01" spread="0.015"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 10 (n=68, 76, 69, 63)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.01" spread="0.014"/>
                    <measurement group_id="O2" value="-0.02" spread="0.015"/>
                    <measurement group_id="O3" value="-0.02" spread="0.013"/>
                    <measurement group_id="O4" value="0.01" spread="0.015"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 12 (n=83, 88, 87, 82)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.024"/>
                    <measurement group_id="O2" value="-0.02" spread="0.014"/>
                    <measurement group_id="O3" value="-0.01" spread="0.015"/>
                    <measurement group_id="O4" value="-0.02" spread="0.013"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 14 (n=76, 77, 80, 75)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.01" spread="0.015"/>
                    <measurement group_id="O2" value="-0.01" spread="0.017"/>
                    <measurement group_id="O3" value="-0.01" spread="0.019"/>
                    <measurement group_id="O4" value="-0.01" spread="0.017"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 16 (n=90, 91, 83, 71)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.010"/>
                    <measurement group_id="O2" value="-0.02" spread="0.014"/>
                    <measurement group_id="O3" value="-0.03" spread="0.014"/>
                    <measurement group_id="O4" value="-0.00" spread="0.018"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 18 (n=78, 75, 82, 71)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.011"/>
                    <measurement group_id="O2" value="-0.02" spread="0.018"/>
                    <measurement group_id="O3" value="-0.03" spread="0.013"/>
                    <measurement group_id="O4" value="0.00" spread="0.020"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 20 (n=83, 79, 78, 72)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.012"/>
                    <measurement group_id="O2" value="-0.03" spread="0.015"/>
                    <measurement group_id="O3" value="-0.04" spread="0.012"/>
                    <measurement group_id="O4" value="-0.03" spread="0.016"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 22 (n=77, 74, 75, 65)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.00" spread="0.015"/>
                    <measurement group_id="O2" value="-0.03" spread="0.013"/>
                    <measurement group_id="O3" value="-0.04" spread="0.012"/>
                    <measurement group_id="O4" value="-0.02" spread="0.016"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 24 (n=83, 81, 78, 74)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.013"/>
                    <measurement group_id="O2" value="-0.03" spread="0.015"/>
                    <measurement group_id="O3" value="-0.03" spread="0.011"/>
                    <measurement group_id="O4" value="-0.04" spread="0.016"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 30 (n=76, 78, 79, 67)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.03" spread="0.013"/>
                    <measurement group_id="O2" value="-0.03" spread="0.017"/>
                    <measurement group_id="O3" value="-0.02" spread="0.011"/>
                    <measurement group_id="O4" value="-0.03" spread="0.016"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 37 (n=74, 72, 70, 60)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.03" spread="0.010"/>
                    <measurement group_id="O2" value="-0.01" spread="0.019"/>
                    <measurement group_id="O3" value="-0.04" spread="0.012"/>
                    <measurement group_id="O4" value="-0.02" spread="0.020"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 50 (n=67, 69, 71, 61)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.03" spread="0.013"/>
                    <measurement group_id="O2" value="-0.01" spread="0.019"/>
                    <measurement group_id="O3" value="-0.02" spread="0.011"/>
                    <measurement group_id="O4" value="-0.01" spread="0.018"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 63 (n=60, 66, 67, 55)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.00" spread="0.019"/>
                    <measurement group_id="O2" value="0.00" spread="0.025"/>
                    <measurement group_id="O3" value="-0.00" spread="0.017"/>
                    <measurement group_id="O4" value="-0.02" spread="0.013"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 76 (n=51, 58, 63, 49)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.03" spread="0.014"/>
                    <measurement group_id="O2" value="-0.04" spread="0.022"/>
                    <measurement group_id="O3" value="-0.02" spread="0.013"/>
                    <measurement group_id="O4" value="-0.03" spread="0.020"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 89 (n=48, 58, 56, 42)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.03" spread="0.019"/>
                    <measurement group_id="O2" value="-0.02" spread="0.025"/>
                    <measurement group_id="O3" value="-0.02" spread="0.013"/>
                    <measurement group_id="O4" value="-0.02" spread="0.020"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 102 (n=39, 47, 50, 40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.025"/>
                    <measurement group_id="O2" value="0.01" spread="0.027"/>
                    <measurement group_id="O3" value="0.02" spread="0.016"/>
                    <measurement group_id="O4" value="-0.01" spread="0.018"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 115 (n=34, 43, 42, 34)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.00" spread="0.019"/>
                    <measurement group_id="O2" value="0.07" spread="0.051"/>
                    <measurement group_id="O3" value="-0.01" spread="0.019"/>
                    <measurement group_id="O4" value="-0.00" spread="0.023"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 128 (n=30, 40, 40, 29)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.017"/>
                    <measurement group_id="O2" value="0.02" spread="0.046"/>
                    <measurement group_id="O3" value="-0.03" spread="0.014"/>
                    <measurement group_id="O4" value="-0.01" spread="0.025"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 141 (n=28, 38, 34, 28)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.01" spread="0.020"/>
                    <measurement group_id="O2" value="-0.00" spread="0.019"/>
                    <measurement group_id="O3" value="-0.00" spread="0.016"/>
                    <measurement group_id="O4" value="0.01" spread="0.020"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 154 (n=26, 33, 31, 24)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.017"/>
                    <measurement group_id="O2" value="-0.00" spread="0.019"/>
                    <measurement group_id="O3" value="-0.01" spread="0.018"/>
                    <measurement group_id="O4" value="0.03" spread="0.021"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 167 (n=24, 33, 30, 25)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.014"/>
                    <measurement group_id="O2" value="-0.02" spread="0.020"/>
                    <measurement group_id="O3" value="0.01" spread="0.017"/>
                    <measurement group_id="O4" value="0.06" spread="0.039"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 180 (n=21, 28, 28, 26)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.013"/>
                    <measurement group_id="O2" value="-0.01" spread="0.021"/>
                    <measurement group_id="O3" value="-0.00" spread="0.014"/>
                    <measurement group_id="O4" value="0.07" spread="0.040"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 193 (n=19, 25, 26, 23)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.01" spread="0.019"/>
                    <measurement group_id="O2" value="-0.01" spread="0.024"/>
                    <measurement group_id="O3" value="0.00" spread="0.017"/>
                    <measurement group_id="O4" value="0.05" spread="0.032"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 206 (n=17, 22, 23, 21)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.026"/>
                    <measurement group_id="O2" value="-0.00" spread="0.028"/>
                    <measurement group_id="O3" value="0.03" spread="0.016"/>
                    <measurement group_id="O4" value="0.06" spread="0.026"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Changes From Baseline in Systolic Blood Pressure During the ST + LT Period</title>
        <time_frame>Baseline, Weeks 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
        <population>Treated participants; n=number of treated participants with measurement at time point</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg</title>
            <description>Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg</title>
            <description>Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
            <description>Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)</description>
          </group>
        </group_list>
        <measure>
          <title>Changes From Baseline in Systolic Blood Pressure During the ST + LT Period</title>
          <population>Treated participants; n=number of treated participants with measurement at time point</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="102"/>
                <count group_id="O2" value="106"/>
                <count group_id="O3" value="98"/>
                <count group_id="O4" value="95"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Change from BL at Week 2 (n=96, 100, 94, 89)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.0" spread="1.4"/>
                    <measurement group_id="O2" value="-2.0" spread="1.3"/>
                    <measurement group_id="O3" value="-2.3" spread="1.2"/>
                    <measurement group_id="O4" value="-3.1" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 4 (n=96, 100, 92, 91)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.9" spread="1.4"/>
                    <measurement group_id="O2" value="-1.2" spread="1.1"/>
                    <measurement group_id="O3" value="-2.3" spread="1.1"/>
                    <measurement group_id="O4" value="-4.3" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 6 (n=91, 98, 88, 84)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.5" spread="1.4"/>
                    <measurement group_id="O2" value="-2.1" spread="1.2"/>
                    <measurement group_id="O3" value="-3.5" spread="1.3"/>
                    <measurement group_id="O4" value="-4.5" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 8 (n=94, 91, 91, 80)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.0" spread="1.4"/>
                    <measurement group_id="O2" value="-1.8" spread="1.2"/>
                    <measurement group_id="O3" value="-4.0" spread="1.2"/>
                    <measurement group_id="O4" value="-5.5" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 10 (n=51, 66, 51, 50)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.6" spread="2.0"/>
                    <measurement group_id="O2" value="-2.9" spread="1.5"/>
                    <measurement group_id="O3" value="-5.0" spread="1.5"/>
                    <measurement group_id="O4" value="-6.1" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 12 (n=82, 83, 87, 79)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.3" spread="1.3"/>
                    <measurement group_id="O2" value="-2.9" spread="1.2"/>
                    <measurement group_id="O3" value="-2.8" spread="1.3"/>
                    <measurement group_id="O4" value="-3.2" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 14 (n=65, 72, 66, 62)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.9" spread="1.6"/>
                    <measurement group_id="O2" value="-2.0" spread="1.5"/>
                    <measurement group_id="O3" value="-6.0" spread="1.7"/>
                    <measurement group_id="O4" value="-1.9" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 16 (n=87, 87, 81, 72)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.2" spread="1.4"/>
                    <measurement group_id="O2" value="-2.1" spread="1.3"/>
                    <measurement group_id="O3" value="-3.8" spread="1.4"/>
                    <measurement group_id="O4" value="-2.1" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 18 (n=73, 69, 76, 66)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.1" spread="1.7"/>
                    <measurement group_id="O2" value="-0.9" spread="1.5"/>
                    <measurement group_id="O3" value="-4.3" spread="1.7"/>
                    <measurement group_id="O4" value="-4.7" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 20 (n=84, 80, 76, 73)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.0" spread="1.6"/>
                    <measurement group_id="O2" value="-3.2" spread="1.3"/>
                    <measurement group_id="O3" value="-3.3" spread="1.4"/>
                    <measurement group_id="O4" value="-4.9" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 22 (n=78, 73, 76, 64)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6.1" spread="1.7"/>
                    <measurement group_id="O2" value="-4.5" spread="1.3"/>
                    <measurement group_id="O3" value="-5.9" spread="1.5"/>
                    <measurement group_id="O4" value="-3.9" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 24 (n=84, 83, 77, 75)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.8" spread="1.5"/>
                    <measurement group_id="O2" value="-4.1" spread="1.2"/>
                    <measurement group_id="O3" value="-6.2" spread="1.5"/>
                    <measurement group_id="O4" value="-6.3" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 30 (n=79, 78, 79, 66)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.6" spread="1.7"/>
                    <measurement group_id="O2" value="-3.8" spread="1.5"/>
                    <measurement group_id="O3" value="-3.9" spread="1.5"/>
                    <measurement group_id="O4" value="-5.4" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 37 (n=77, 74, 71, 66)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.0" spread="1.7"/>
                    <measurement group_id="O2" value="-3.5" spread="1.4"/>
                    <measurement group_id="O3" value="-5.2" spread="1.5"/>
                    <measurement group_id="O4" value="-3.6" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 50 (n=70, 73, 73, 62)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.5" spread="1.7"/>
                    <measurement group_id="O2" value="0.1" spread="1.4"/>
                    <measurement group_id="O3" value="-3.3" spread="1.5"/>
                    <measurement group_id="O4" value="-0.4" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 63 (n=62, 66, 69, 56)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.2" spread="1.9"/>
                    <measurement group_id="O2" value="-0.3" spread="1.4"/>
                    <measurement group_id="O3" value="-1.1" spread="1.5"/>
                    <measurement group_id="O4" value="-2.4" spread="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 76 (n=53, 59, 64, 50)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.9" spread="1.7"/>
                    <measurement group_id="O2" value="-2.6" spread="1.6"/>
                    <measurement group_id="O3" value="-3.1" spread="1.8"/>
                    <measurement group_id="O4" value="-0.9" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 89 (n=49, 58, 56, 44)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.8" spread="2.0"/>
                    <measurement group_id="O2" value="-3.4" spread="1.4"/>
                    <measurement group_id="O3" value="-5.4" spread="2.0"/>
                    <measurement group_id="O4" value="-2.2" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 102 (n=42, 47, 50, 40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.6" spread="2.1"/>
                    <measurement group_id="O2" value="-1.1" spread="1.9"/>
                    <measurement group_id="O3" value="-2.9" spread="2.1"/>
                    <measurement group_id="O4" value="-1.0" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 115 (n=34, 43, 43, 37)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.6" spread="2.4"/>
                    <measurement group_id="O2" value="-2.6" spread="2.0"/>
                    <measurement group_id="O3" value="-1.6" spread="1.9"/>
                    <measurement group_id="O4" value="0.9" spread="2.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 128 (n=31, 40, 41, 31)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.1" spread="2.5"/>
                    <measurement group_id="O2" value="-5.5" spread="1.9"/>
                    <measurement group_id="O3" value="0.0" spread="1.9"/>
                    <measurement group_id="O4" value="1.1" spread="2.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 141 (n=29, 40, 35, 29)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.8" spread="3.0"/>
                    <measurement group_id="O2" value="-5.2" spread="2.3"/>
                    <measurement group_id="O3" value="0.3" spread="2.6"/>
                    <measurement group_id="O4" value="-1.4" spread="3.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 154 (n=27, 36, 33, 27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.8" spread="2.8"/>
                    <measurement group_id="O2" value="-0.5" spread="2.3"/>
                    <measurement group_id="O3" value="3.5" spread="2.6"/>
                    <measurement group_id="O4" value="2.3" spread="3.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 167 (n=24, 33, 30, 27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.7" spread="2.9"/>
                    <measurement group_id="O2" value="-1.8" spread="2.5"/>
                    <measurement group_id="O3" value="4.0" spread="2.5"/>
                    <measurement group_id="O4" value="-0.6" spread="3.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 180 (n=21, 28, 28, 27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9" spread="2.9"/>
                    <measurement group_id="O2" value="-5.4" spread="3.2"/>
                    <measurement group_id="O3" value="0.9" spread="2.4"/>
                    <measurement group_id="O4" value="-0.8" spread="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 193 (n=19, 26, 27, 24)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.4" spread="4.0"/>
                    <measurement group_id="O2" value="-7.5" spread="3.2"/>
                    <measurement group_id="O3" value="0.0" spread="3.0"/>
                    <measurement group_id="O4" value="-2.6" spread="3.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 206 (n=17, 24, 24, 23)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.8" spread="5.0"/>
                    <measurement group_id="O2" value="-2.8" spread="3.3"/>
                    <measurement group_id="O3" value="2.3" spread="2.6"/>
                    <measurement group_id="O4" value="0.7" spread="4.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Changes From Baseline in Diastolic Blood Pressure During the ST + LT Period</title>
        <time_frame>Baseline, Weeks 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
        <population>Treated participants; n=number of treated participants with measurement at time point</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg</title>
            <description>Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg</title>
            <description>Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
            <description>Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)</description>
          </group>
        </group_list>
        <measure>
          <title>Changes From Baseline in Diastolic Blood Pressure During the ST + LT Period</title>
          <population>Treated participants; n=number of treated participants with measurement at time point</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="102"/>
                <count group_id="O2" value="106"/>
                <count group_id="O3" value="98"/>
                <count group_id="O4" value="95"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Change from BL at Week 2 (n=96, 100, 94, 89)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.0" spread="0.7"/>
                    <measurement group_id="O2" value="-1.2" spread="0.8"/>
                    <measurement group_id="O3" value="-0.5" spread="0.7"/>
                    <measurement group_id="O4" value="-1.5" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 4 (n=96, 100, 92, 91)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.4" spread="0.7"/>
                    <measurement group_id="O2" value="-1.1" spread="0.8"/>
                    <measurement group_id="O3" value="0.3" spread="0.8"/>
                    <measurement group_id="O4" value="-1.8" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 6 (n=91, 98, 88, 84)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.5" spread="0.8"/>
                    <measurement group_id="O2" value="-0.9" spread="0.8"/>
                    <measurement group_id="O3" value="-0.8" spread="0.9"/>
                    <measurement group_id="O4" value="-1.9" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 8 (n=94, 91, 91, 80)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.4" spread="0.9"/>
                    <measurement group_id="O2" value="-0.9" spread="0.8"/>
                    <measurement group_id="O3" value="-0.7" spread="0.8"/>
                    <measurement group_id="O4" value="-2.4" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 10 (n=51, 66, 51, 50)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.8" spread="1.2"/>
                    <measurement group_id="O2" value="-1.1" spread="1.1"/>
                    <measurement group_id="O3" value="-1.3" spread="0.9"/>
                    <measurement group_id="O4" value="-3.4" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 12 (n=82, 83, 87, 79)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.3" spread="0.9"/>
                    <measurement group_id="O2" value="-2.0" spread="0.9"/>
                    <measurement group_id="O3" value="-0.7" spread="0.8"/>
                    <measurement group_id="O4" value="-1.8" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 14 (n=65, 72, 66, 62)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.5" spread="0.9"/>
                    <measurement group_id="O2" value="-2.4" spread="1.1"/>
                    <measurement group_id="O3" value="-2.4" spread="1.0"/>
                    <measurement group_id="O4" value="-2.7" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 16 (n=87, 87, 81, 72)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.5" spread="0.9"/>
                    <measurement group_id="O2" value="-0.5" spread="0.8"/>
                    <measurement group_id="O3" value="-0.1" spread="0.9"/>
                    <measurement group_id="O4" value="-2.1" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 18 (n=73, 69, 76, 66)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.3" spread="1.0"/>
                    <measurement group_id="O2" value="-1.6" spread="0.9"/>
                    <measurement group_id="O3" value="-1.9" spread="0.9"/>
                    <measurement group_id="O4" value="-2.1" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 20 (n=84, 80, 76, 73)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.2" spread="0.9"/>
                    <measurement group_id="O2" value="-1.8" spread="0.9"/>
                    <measurement group_id="O3" value="-1.9" spread="1.0"/>
                    <measurement group_id="O4" value="-2.2" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 22 (n=78, 73, 76, 64)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.0" spread="0.9"/>
                    <measurement group_id="O2" value="-2.0" spread="0.9"/>
                    <measurement group_id="O3" value="-2.5" spread="0.9"/>
                    <measurement group_id="O4" value="-1.7" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 24 (n=84, 83, 77, 75)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.5" spread="1.0"/>
                    <measurement group_id="O2" value="-1.7" spread="0.8"/>
                    <measurement group_id="O3" value="-2.3" spread="0.9"/>
                    <measurement group_id="O4" value="-3.4" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 30 (n=79, 78, 79, 66)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.4" spread="0.9"/>
                    <measurement group_id="O2" value="-2.2" spread="0.9"/>
                    <measurement group_id="O3" value="-0.3" spread="0.9"/>
                    <measurement group_id="O4" value="-2.8" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 37 (n=77, 74, 71, 66)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.4" spread="1.1"/>
                    <measurement group_id="O2" value="-1.7" spread="0.9"/>
                    <measurement group_id="O3" value="-0.6" spread="1.0"/>
                    <measurement group_id="O4" value="-2.0" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 50 (n=70, 73, 73, 62)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.7" spread="1.2"/>
                    <measurement group_id="O2" value="0.3" spread="0.8"/>
                    <measurement group_id="O3" value="-0.3" spread="1.0"/>
                    <measurement group_id="O4" value="-0.6" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 63 (n=61, 66, 69, 56)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.1" spread="1.2"/>
                    <measurement group_id="O2" value="-0.4" spread="1.0"/>
                    <measurement group_id="O3" value="-0.0" spread="1.0"/>
                    <measurement group_id="O4" value="-0.5" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 76 (n=53, 59, 64, 50)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.6" spread="1.2"/>
                    <measurement group_id="O2" value="-2.0" spread="0.8"/>
                    <measurement group_id="O3" value="0.1" spread="1.1"/>
                    <measurement group_id="O4" value="-0.3" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 89 (n=49, 58, 56, 44)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4" spread="1.2"/>
                    <measurement group_id="O2" value="-2.1" spread="1.0"/>
                    <measurement group_id="O3" value="-1.6" spread="1.2"/>
                    <measurement group_id="O4" value="-0.1" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 102 (n=42, 51, 51, 42)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.1" spread="1.3"/>
                    <measurement group_id="O2" value="-2.0" spread="1.2"/>
                    <measurement group_id="O3" value="-0.4" spread="1.2"/>
                    <measurement group_id="O4" value="-1.2" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 115 (n=34, 43, 43, 37)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.9" spread="1.5"/>
                    <measurement group_id="O2" value="-2.7" spread="1.3"/>
                    <measurement group_id="O3" value="-1.1" spread="1.1"/>
                    <measurement group_id="O4" value="-1.0" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 128 (n=31, 40, 41, 31)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.8" spread="1.5"/>
                    <measurement group_id="O2" value="-3.7" spread="1.2"/>
                    <measurement group_id="O3" value="1.1" spread="1.3"/>
                    <measurement group_id="O4" value="1.0" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 141 (n=29, 40, 35, 29)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9" spread="1.5"/>
                    <measurement group_id="O2" value="-2.0" spread="1.5"/>
                    <measurement group_id="O3" value="1.1" spread="1.7"/>
                    <measurement group_id="O4" value="1.3" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 154 (n=27, 36, 33, 27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2" spread="1.7"/>
                    <measurement group_id="O2" value="-0.8" spread="1.3"/>
                    <measurement group_id="O3" value="2.5" spread="1.5"/>
                    <measurement group_id="O4" value="1.3" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 167 (n=24, 33, 30, 27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.8" spread="1.6"/>
                    <measurement group_id="O2" value="0.3" spread="1.4"/>
                    <measurement group_id="O3" value="2.4" spread="1.8"/>
                    <measurement group_id="O4" value="-1.1" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 180 (n=21, 28, 28, 27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4" spread="1.6"/>
                    <measurement group_id="O2" value="-2.0" spread="2.0"/>
                    <measurement group_id="O3" value="0.5" spread="1.7"/>
                    <measurement group_id="O4" value="-0.8" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 193 (n=19, 26, 27, 24)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.8" spread="2.3"/>
                    <measurement group_id="O2" value="-1.6" spread="2.0"/>
                    <measurement group_id="O3" value="0.5" spread="1.7"/>
                    <measurement group_id="O4" value="-0.2" spread="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 206 (n=17, 24, 24, 23)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="3.1"/>
                    <measurement group_id="O2" value="-0.6" spread="2.4"/>
                    <measurement group_id="O3" value="1.9" spread="1.6"/>
                    <measurement group_id="O4" value="-0.2" spread="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Changes From Baseline in Heart Rate During the ST + LT Period</title>
        <time_frame>Baseline, Weeks 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167, 180, 193, 206</time_frame>
        <population>Treated participants; n=number of treated participants with measurement at time point</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg</title>
            <description>Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg</title>
            <description>Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
            <description>Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)</description>
          </group>
        </group_list>
        <measure>
          <title>Changes From Baseline in Heart Rate During the ST + LT Period</title>
          <population>Treated participants; n=number of treated participants with measurement at time point</population>
          <units>beats per minute</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="102"/>
                <count group_id="O2" value="106"/>
                <count group_id="O3" value="98"/>
                <count group_id="O4" value="95"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Change from BL at Week 2 (n=96, 100, 94, 89)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.1" spread="0.9"/>
                    <measurement group_id="O2" value="-0.5" spread="0.8"/>
                    <measurement group_id="O3" value="0.2" spread="0.8"/>
                    <measurement group_id="O4" value="0.3" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 4 (n=96, 100, 92, 91)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="0.9"/>
                    <measurement group_id="O2" value="-1.1" spread="0.8"/>
                    <measurement group_id="O3" value="0.7" spread="0.7"/>
                    <measurement group_id="O4" value="-0.1" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 6 (n=91, 98, 88, 84)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.5" spread="0.9"/>
                    <measurement group_id="O2" value="-0.6" spread="0.8"/>
                    <measurement group_id="O3" value="-0.6" spread="0.8"/>
                    <measurement group_id="O4" value="1.4" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 8 (n=94, 91, 91, 80)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.5" spread="0.9"/>
                    <measurement group_id="O2" value="-0.9" spread="0.8"/>
                    <measurement group_id="O3" value="0.2" spread="0.8"/>
                    <measurement group_id="O4" value="-0.2" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 10 (n=51, 66, 51, 49)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.2" spread="1.2"/>
                    <measurement group_id="O2" value="-1.5" spread="0.9"/>
                    <measurement group_id="O3" value="-1.0" spread="1.2"/>
                    <measurement group_id="O4" value="0.1" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 12 (n=82, 83, 87, 79)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="1.0"/>
                    <measurement group_id="O2" value="-1.2" spread="0.8"/>
                    <measurement group_id="O3" value="0.5" spread="0.9"/>
                    <measurement group_id="O4" value="0.8" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 14 (n=65, 72, 65, 62)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="1.1"/>
                    <measurement group_id="O2" value="-0.5" spread="0.9"/>
                    <measurement group_id="O3" value="0.6" spread="1.1"/>
                    <measurement group_id="O4" value="1.9" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 16 (n=87, 87, 81, 72)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.8" spread="0.9"/>
                    <measurement group_id="O2" value="-1.5" spread="0.9"/>
                    <measurement group_id="O3" value="-0.1" spread="0.9"/>
                    <measurement group_id="O4" value="-0.1" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 18 (n=73, 69, 76, 66)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.0" spread="1.1"/>
                    <measurement group_id="O2" value="-0.8" spread="1.1"/>
                    <measurement group_id="O3" value="1.5" spread="1.0"/>
                    <measurement group_id="O4" value="2.6" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 20 (n=84, 80, 76, 73)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" spread="0.9"/>
                    <measurement group_id="O2" value="-1.5" spread="0.9"/>
                    <measurement group_id="O3" value="1.3" spread="0.9"/>
                    <measurement group_id="O4" value="0.8" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 22 (n=78, 73, 76, 64)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="1.0"/>
                    <measurement group_id="O2" value="-0.3" spread="0.9"/>
                    <measurement group_id="O3" value="0.9" spread="0.9"/>
                    <measurement group_id="O4" value="1.5" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 24 (n=84, 83, 77, 75)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.3" spread="1.1"/>
                    <measurement group_id="O2" value="0.1" spread="1.1"/>
                    <measurement group_id="O3" value="-0.7" spread="0.9"/>
                    <measurement group_id="O4" value="-0.4" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 30 (n=79, 78, 79, 66)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.1" spread="1.0"/>
                    <measurement group_id="O2" value="-1.2" spread="1.1"/>
                    <measurement group_id="O3" value="-0.7" spread="0.8"/>
                    <measurement group_id="O4" value="-1.2" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 37 (n=77, 74, 71, 66)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.4" spread="1.0"/>
                    <measurement group_id="O2" value="-1.4" spread="0.9"/>
                    <measurement group_id="O3" value="0.5" spread="1.0"/>
                    <measurement group_id="O4" value="-0.9" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 50 (n=70, 73, 73, 62)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.1" spread="0.9"/>
                    <measurement group_id="O2" value="-0.7" spread="1.1"/>
                    <measurement group_id="O3" value="-0.2" spread="1.0"/>
                    <measurement group_id="O4" value="-0.2" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 63 (n=62, 66, 69, 56)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.4" spread="1.1"/>
                    <measurement group_id="O2" value="-2.5" spread="1.0"/>
                    <measurement group_id="O3" value="0.9" spread="1.1"/>
                    <measurement group_id="O4" value="0.6" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 76 (n=53, 59, 64, 50)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.3" spread="1.4"/>
                    <measurement group_id="O2" value="-3.3" spread="1.1"/>
                    <measurement group_id="O3" value="0.4" spread="1.1"/>
                    <measurement group_id="O4" value="0.2" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 89 (n=49, 58, 56, 44)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.5" spread="1.4"/>
                    <measurement group_id="O2" value="-1.5" spread="1.2"/>
                    <measurement group_id="O3" value="-0.9" spread="1.1"/>
                    <measurement group_id="O4" value="-0.3" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 102 (n=42, 51, 51, 42)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.8" spread="1.4"/>
                    <measurement group_id="O2" value="-1.5" spread="1.4"/>
                    <measurement group_id="O3" value="-0.1" spread="1.4"/>
                    <measurement group_id="O4" value="-0.0" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 115 (n=34, 43, 43, 37)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.2" spread="1.7"/>
                    <measurement group_id="O2" value="-2.3" spread="1.3"/>
                    <measurement group_id="O3" value="1.0" spread="1.6"/>
                    <measurement group_id="O4" value="0.8" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 128 (n=31, 40, 41, 31)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.1" spread="1.8"/>
                    <measurement group_id="O2" value="-4.5" spread="1.6"/>
                    <measurement group_id="O3" value="-0.7" spread="1.4"/>
                    <measurement group_id="O4" value="1.7" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 141 (n=29, 40, 35, 29)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.8" spread="1.4"/>
                    <measurement group_id="O2" value="-3.5" spread="1.5"/>
                    <measurement group_id="O3" value="-0.6" spread="1.6"/>
                    <measurement group_id="O4" value="0.9" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 154 (n=27, 36, 33, 27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.0" spread="2.1"/>
                    <measurement group_id="O2" value="-2.6" spread="1.6"/>
                    <measurement group_id="O3" value="-1.3" spread="1.8"/>
                    <measurement group_id="O4" value="-0.6" spread="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 167 (n=24, 33, 30, 27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.1" spread="1.9"/>
                    <measurement group_id="O2" value="-0.8" spread="1.4"/>
                    <measurement group_id="O3" value="-2.1" spread="2.4"/>
                    <measurement group_id="O4" value="0.5" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 180 (n=21, 28, 28, 27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.1" spread="2.1"/>
                    <measurement group_id="O2" value="-5.3" spread="1.8"/>
                    <measurement group_id="O3" value="-2.0" spread="2.0"/>
                    <measurement group_id="O4" value="-1.2" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 193 (n=19, 26, 27, 24)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.6" spread="2.4"/>
                    <measurement group_id="O2" value="-4.2" spread="1.8"/>
                    <measurement group_id="O3" value="-2.4" spread="2.0"/>
                    <measurement group_id="O4" value="1.1" spread="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 206 (n=17, 24, 24, 23)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.3" spread="2.6"/>
                    <measurement group_id="O2" value="-2.6" spread="1.9"/>
                    <measurement group_id="O3" value="0.0" spread="2.7"/>
                    <measurement group_id="O4" value="-0.8" spread="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Electrocardiogram (ECG) Tracings - Shift Table From Baseline (BL) to Selected Visits During ST + LT Treatment Period</title>
        <description>The normality/abnormality of the ECG tracing was determined by the investigator.</description>
        <time_frame>Baseline, Weeks 12, 24, 76, 102, 154, 206</time_frame>
        <population>Treated participants; BL n=number of participants at baseline</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg</title>
            <description>Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg</title>
            <description>Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
            <description>Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)</description>
          </group>
        </group_list>
        <measure>
          <title>Electrocardiogram (ECG) Tracings - Shift Table From Baseline (BL) to Selected Visits During ST + LT Treatment Period</title>
          <description>The normality/abnormality of the ECG tracing was determined by the investigator.</description>
          <population>Treated participants; BL n=number of participants at baseline</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="102"/>
                <count group_id="O2" value="106"/>
                <count group_id="O3" value="98"/>
                <count group_id="O4" value="95"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Normal BL, Normal Week 12 (BL n=65, 66, 67, 47)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57"/>
                    <measurement group_id="O2" value="56"/>
                    <measurement group_id="O3" value="59"/>
                    <measurement group_id="O4" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal BL, Abnormal Week 12 (BL n=65, 66, 67, 47)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal BL, Normal Week 12 (BL n=27, 32, 26, 43)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal BL, Abnormal Week 12(BL n=27, 32, 26, 43)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="26"/>
                    <measurement group_id="O3" value="17"/>
                    <measurement group_id="O4" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal BL, Normal Week 24 (BL n=53, 52, 47, 33)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43"/>
                    <measurement group_id="O2" value="44"/>
                    <measurement group_id="O3" value="43"/>
                    <measurement group_id="O4" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal BL, Abnormal Week 24 (BL n=53, 52, 47, 33)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal BL, Normal Week 24 (BL n=19, 24, 21, 25)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal BL, Abnormal Week 24(BL n=19, 24, 21, 25)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="16"/>
                    <measurement group_id="O3" value="12"/>
                    <measurement group_id="O4" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal BL, Normal Week 76 (BL n=48, 49, 48, 36)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37"/>
                    <measurement group_id="O2" value="44"/>
                    <measurement group_id="O3" value="40"/>
                    <measurement group_id="O4" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal BL, Abnormal Week 76 (BL n=48, 49, 48, 36)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal BL, Normal Week 76 (BL n=19, 23, 21, 27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal BL, Abnormal Week 76(BL n=19, 23, 21, 27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal BL, Normal Week 102 (BL n=32, 32, 36, 22)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                    <measurement group_id="O2" value="26"/>
                    <measurement group_id="O3" value="31"/>
                    <measurement group_id="O4" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal BL, Abnormal Week 102 (BL n=32, 32, 36, 22)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal BL, Normal Week 102 (BL n=12, 18, 17, 20)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="12"/>
                    <measurement group_id="O4" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal BL,Abnormal Week 102(BL n=12, 18, 17, 20)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal BL, Normal Week 154 (BL n=20, 21, 26, 15)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="17"/>
                    <measurement group_id="O3" value="23"/>
                    <measurement group_id="O4" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal BL, Abnormal Week 154 (BL n=20, 21, 26, 15)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal BL, Normal Week 154 (BL n=7, 16, 11, 13)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal BL, Abnormal Week 154(BL n=7, 16, 11, 13)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal BL, Normal Week 206 (BL n=15, 13, 20, 14)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="18"/>
                    <measurement group_id="O4" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal BL, Abnormal Week 206 (BL n=15, 13, 20, 14)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal BL, Normal Week 206 (BL n=4, 13, 8, 11)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal BL, Abnormal Week 206 (BL n=4, 13, 8, 11)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Overall Summary of Adverse Events During ST+LT Treatment Period - Open-Label Cohort</title>
        <description>AE=any new untoward medical occurrence or worsening of a pre-existing medical condition which does not necessarily have a causal relationship with this treatment. SAE=any untoward medical occurrence that at any dose: results in death, is life-threatening, requires inpatient hospitalization or causes prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect, results in development of drug dependency or drug abuse, is an important medical event. Related events=relationship of certain, probable, possible, or missing.</description>
        <time_frame>AEs: up to last treatment day + 1 day or last visit; SAEs: up to last treatment day + 30 days or last visit + 30 days. Mean duration of exposure was 34 weeks.</time_frame>
        <population>All treated participants</population>
        <group_list>
          <group group_id="O1">
            <title>Open-Label Treatment Cohort (Direct Enrollees)</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Summary of Adverse Events During ST+LT Treatment Period - Open-Label Cohort</title>
          <description>AE=any new untoward medical occurrence or worsening of a pre-existing medical condition which does not necessarily have a causal relationship with this treatment. SAE=any untoward medical occurrence that at any dose: results in death, is life-threatening, requires inpatient hospitalization or causes prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect, results in development of drug dependency or drug abuse, is an important medical event. Related events=relationship of certain, probable, possible, or missing.</description>
          <population>All treated participants</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>At Least 1 AE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At Least 1 Related AE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Deaths</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At Least 1 SAE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At Least 1 Related SAE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discontinuations Due to SAEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discontinuations Due to AEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Marked Laboratory Abnormalities During ST + LT Treatment Period - Open-Label Cohort</title>
        <description>A laboratory value was considered a marked abnormality if it is outside the pre-defined criteria for marked abnormality and the on-treatment value was more extreme (farther from the limit) than the baseline value. Pre-Rx=pretreatment; ULN=upper limit of normal; ALP=alkaline phosphatase; AST=aspartate aminotransferase; ALT=alanine aminotransferase; unspec=unspecified; sodium serum low: &lt;0.9 x Pre-Rx &amp; &lt;=130mEq/L / high: &gt;1.1 x Pre-Rx &amp; &gt;=150mEq/L; potassium, serum low: &lt;=0.8 x Pre-Rx &amp; &gt;=6.0mEq/L / high: 1.2 x Pre-Rx &amp; &gt;=6.0mEq/L; LLN=lower limit of normal.</description>
        <time_frame>Lab assessments taken during and up to 14 days after the last dose of study drug during the ST + LT Treatment Period. Mean duration of exposure was 34 weeks.</time_frame>
        <population>Number of Participants Analyzed=Treated participants; n=number of treated subjects with baseline value and at least one value during the ST + LT treatment period</population>
        <group_list>
          <group group_id="O1">
            <title>Open-Label Treatment Cohort (Direct Enrollees)</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>Marked Laboratory Abnormalities During ST + LT Treatment Period - Open-Label Cohort</title>
          <description>A laboratory value was considered a marked abnormality if it is outside the pre-defined criteria for marked abnormality and the on-treatment value was more extreme (farther from the limit) than the baseline value. Pre-Rx=pretreatment; ULN=upper limit of normal; ALP=alkaline phosphatase; AST=aspartate aminotransferase; ALT=alanine aminotransferase; unspec=unspecified; sodium serum low: &lt;0.9 x Pre-Rx &amp; &lt;=130mEq/L / high: &gt;1.1 x Pre-Rx &amp; &gt;=150mEq/L; potassium, serum low: &lt;=0.8 x Pre-Rx &amp; &gt;=6.0mEq/L / high: 1.2 x Pre-Rx &amp; &gt;=6.0mEq/L; LLN=lower limit of normal.</description>
          <population>Number of Participants Analyzed=Treated participants; n=number of treated subjects with baseline value and at least one value during the ST + LT treatment period</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="102"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Hemoglobin &lt; 8 g/dL (n=64)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hematocrit &lt; 0.75 x pre-Rx (n=64)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Platelets &lt; 50 x 10^9 c/L (n=64)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Platelets &gt; 1.5 x ULN (n=64)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Leukocytes &lt; 2 x 1000 c/µL (n=64)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Neutrophils+Bands &lt;1x1000 c/uL (n=64)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Eosinophils &gt;0.9x1000 c/µL (n=64)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lymphocytes &lt;=0.75x1000 c/uL (n=64)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ALP &gt;3 x pre-Rx and &gt;ULN (n=64)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ALP &gt;1.5 x ULN (n=64)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AST &gt;3 x ULN (n=64)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AST &gt;5 x ULN (n=64)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AST &gt;10 x ULN (n=64)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AST &gt;20 x ULN (n=64)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ALT &gt;3 x ULN (n=64)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ALT &gt;5 x ULN (n=64)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ALT &gt;10 x ULN (n=64)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ALT &gt;20 x ULN (n=64)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bilirubin Total &gt;2mg/dL (n=64)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bilirubin Total &gt;1.5xULN (n=64)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bilirubin Total &gt;2xULN (n=64)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BUN &gt;2 x pre-Rx and &gt;ULN (n=64)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Creatinine &gt;2.5 mg/dL (n=64)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Glucose, Serum Fasting &lt; 50 mg/dL (n=1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Glucose, Serum Fasting &gt; 500 mg/dL (n=1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Glucose, Serum Unspec. &lt; 50 mg/dL (n=1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Glucose, Serum Unspec. &gt; 500 mg/dL (n=1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Glucose, Plasma Fasting &lt;50 mg/dL (n=64)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Glucose,Plasma Fasting &gt;500 mg/dL (n=64)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Glucose, Plasma Unspec. &lt;50 mg/dL (n=65)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Glucose,Plasma Unspec. &gt;500 mg/dL (n=65)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sodium,Serum Low (see above) (n=65)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sodium,Serum High (see above) (n=65)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Potassium,Serum Low (see above) (n=65)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Potassium, Serum High (see above) (n=65)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chloride &lt; 90 mEq/L (n=65)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chloride &gt; 120 mEq/L (n=65)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Albumin &lt; 0.9 LLN (n=64)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Creatine Kinase &gt; 5 x ULN (n=64)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Uric Acid &gt; 1.5 x ULN (n=0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Protein Urine, &gt;=2-4 (n=64)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Blood Urine, &gt;=2-4 (n=64)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Red Blood Cells Urine &gt;=2-4 (n=58)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White Blood Cells Urine &gt;=2-4 (n=58)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>All Reported Hypoglycemic Adverse Events During ST + LT Treatment Period</title>
        <description>Hypoglycemic Events are based upon the Saxagliptin Predefined List of Events, which included hypoglycemia, blood glucose decreased, and hypoglycemic unconsciousness.</description>
        <time_frame>AEs: up to last treatment day + 1 day or last visit; SAEs: up to last treatment day + 30 days or last visit + 30 days. Mean duration of exposure was 109 weeks in 10 mg arm, 94.7 weeks in 2.5 mg arm, 103 weeks in 5 mg arm, and 98.4 weeks in placebo arm.</time_frame>
        <population>Treated participants</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg</title>
            <description>Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg</title>
            <description>Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
            <description>Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)</description>
          </group>
        </group_list>
        <measure>
          <title>All Reported Hypoglycemic Adverse Events During ST + LT Treatment Period</title>
          <description>Hypoglycemic Events are based upon the Saxagliptin Predefined List of Events, which included hypoglycemia, blood glucose decreased, and hypoglycemic unconsciousness.</description>
          <population>Treated participants</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="102"/>
                <count group_id="O2" value="106"/>
                <count group_id="O3" value="98"/>
                <count group_id="O4" value="95"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Confirmed Hypoglycemia During ST + LT Treatment Period</title>
        <description>'Confirmed' = recorded on the hypoglycemia AE case report form page with a fingerstick glucose &lt;= 50 mg/dL and associated symptoms</description>
        <time_frame>AEs: up to last treatment day + 1 day or last visit; SAEs: up to last treatment day + 30 days or last visit + 30 days. Mean duration of exposure was 109 weeks in 10 mg arm, 94.7 weeks in 2.5 mg arm, 103 weeks in 5 mg arm, and 98.4 weeks in placebo arm.</time_frame>
        <population>Treated participants</population>
        <group_list>
          <group group_id="O1">
            <title>Saxagliptin 2.5 mg</title>
            <description>Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O2">
            <title>Saxagliptin 5 mg</title>
            <description>Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O3">
            <title>Saxagliptin 10 mg</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
          <group group_id="O4">
            <title>Placebo</title>
            <description>Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)</description>
          </group>
        </group_list>
        <measure>
          <title>Confirmed Hypoglycemia During ST + LT Treatment Period</title>
          <description>'Confirmed' = recorded on the hypoglycemia AE case report form page with a fingerstick glucose &lt;= 50 mg/dL and associated symptoms</description>
          <population>Treated participants</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="102"/>
                <count group_id="O2" value="106"/>
                <count group_id="O3" value="98"/>
                <count group_id="O4" value="95"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>All Reported Hypoglycemic Adverse Events During ST + LT Treatment Period - Open-Label Cohort</title>
        <description>Hypoglycemic Events are based upon the Saxagliptin Predefined List of Events, which included hypoglycemia, blood glucose decreased, and hypoglycemic unconsciousness.</description>
        <time_frame>AEs: up to last treatment day + 1 day or last visit; SAEs: up to last treatment day + 30 days or last visit + 30 days. Mean duration of exposure was 34 weeks.</time_frame>
        <population>Treated participants</population>
        <group_list>
          <group group_id="O1">
            <title>Open-Label Treatment Cohort (Direct Enrollees)</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>All Reported Hypoglycemic Adverse Events During ST + LT Treatment Period - Open-Label Cohort</title>
          <description>Hypoglycemic Events are based upon the Saxagliptin Predefined List of Events, which included hypoglycemia, blood glucose decreased, and hypoglycemic unconsciousness.</description>
          <population>Treated participants</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="102"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Confirmed Hypoglycemia During ST + LT Treatment Period - Open-Label Cohort</title>
        <description>'Confirmed' = recorded on the hypoglycemia AE case report form page with a fingerstick glucose &lt;= 50 mg/dL and associated symptoms</description>
        <time_frame>AEs: up to last treatment day + 1 day or last visit; SAEs: up to last treatment day + 30 days or last visit + 30 days. Mean duration of exposure was 34 weeks.</time_frame>
        <population>Treated participants</population>
        <group_list>
          <group group_id="O1">
            <title>Open-Label Treatment Cohort (Direct Enrollees)</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>Confirmed Hypoglycemia During ST + LT Treatment Period - Open-Label Cohort</title>
          <description>'Confirmed' = recorded on the hypoglycemia AE case report form page with a fingerstick glucose &lt;= 50 mg/dL and associated symptoms</description>
          <population>Treated participants</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Electrocardiogram (ECG) Tracings - Shift Table From Baseline (BL) to Selected Visits During ST + LT Treatment Period - Open Label Cohort</title>
        <description>The normality/abnormality of the ECG tracing was determined by the investigator.</description>
        <time_frame>Baseline, Weeks 12, 24, 76, 102, 154, 206</time_frame>
        <population>Treated participants; BL n=number of participants at baseline</population>
        <group_list>
          <group group_id="O1">
            <title>Open-Label Treatment Cohort (Direct Enrollees)</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>Electrocardiogram (ECG) Tracings - Shift Table From Baseline (BL) to Selected Visits During ST + LT Treatment Period - Open Label Cohort</title>
          <description>The normality/abnormality of the ECG tracing was determined by the investigator.</description>
          <population>Treated participants; BL n=number of participants at baseline</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Normal BL, Normal Week 12 (BL n=23)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal BL, Abnormal Week 12 (BL n=23)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal BL, Normal Week 12 (BL n=18)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal BL, Abnormal Week 12 (BL n=18)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal BL, Normal Week 24 (BL n=10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal BL, Abnormal Week 24 (BL n=10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal BL, Normal Week 24 (BL n=6)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal BL, Abnormal Week 24(BL n=6)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal BL, Normal Week 76 (BL n=17)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal BL, Abnormal Week 76 (BL n=17)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal BL, Normal Week 76 (BL n=13)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal BL, Abnormal Week 76 (BL n=13)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal BL, Normal Week 102 (BL n=8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal BL, Abnormal Week 102 (BL n=8)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal BL, Normal Week 102 (BL n=4)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal BL, Abnormal Week 102 (BL n=4)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal BL, Normal Week 154 (BL n=4)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal BL, Abnormal Week 154 (BL n=4)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal BL, Normal Week 154 (BL n=2)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal BL, Abnormal Week 154 (BL n=2)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal BL, Normal Week 206 (BL n=3)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Normal BL, Abnormal Week 206 (BL n=3)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal BL, Normal Week 206 (BL n=1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abnormal BL, Abnormal Week 206 (BL n=1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Changes From Baseline in Systolic Blood Pressure During the ST + LT Period - Open Label Cohort</title>
        <time_frame>Baseline, Weeks 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167</time_frame>
        <population>Treated participants; n=number of treated participants with measurement at time point</population>
        <group_list>
          <group group_id="O1">
            <title>Open-Label Treatment Cohort (Direct Enrollees)</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>Changes From Baseline in Systolic Blood Pressure During the ST + LT Period - Open Label Cohort</title>
          <population>Treated participants; n=number of treated participants with measurement at time point</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Change from BL at Week 2 (n=62)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.4" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 4 (n=59)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.8" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 6 (n=60)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.7" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 8 (n=49)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.1" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 10 (n=24)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.2" spread="2.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 12 (n=47)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.9" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 14 (n=35)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.1" spread="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 16 (n=46)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.9" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 18 (n=42)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.8" spread="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 20 (n=45)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.6" spread="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 22 (n=44)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.0" spread="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 24 (n=44)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.3" spread="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 30 (n=40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.8" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 37 (n=35)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.7" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 50 (n=36)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.6" spread="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 63 (n=26)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.7" spread="2.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 76 (n=24)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.9" spread="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 89 (n=23)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.0" spread="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 102 (n=15)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9" spread="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 115 (n=13)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6.6" spread="3.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 128 (n=11)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.6" spread="4.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 141 (n=10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-7.2" spread="4.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 154 (n=10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.7" spread="4.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 167 (n=10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.2" spread="4.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Changes From Baseline in Diastolic Blood Pressure During the ST + LT Period - Open Label Cohort</title>
        <time_frame>Baseline, Weeks 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167</time_frame>
        <population>Treated participants; n=number of treated participants with measurement at time point</population>
        <group_list>
          <group group_id="O1">
            <title>Open-Label Treatment Cohort (Direct Enrollees)</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>Changes From Baseline in Diastolic Blood Pressure During the ST + LT Period - Open Label Cohort</title>
          <population>Treated participants; n=number of treated participants with measurement at time point</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Change from BL at Week 2 (n=62)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.7" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 4 (n=59)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.7" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 6 (n=60)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.8" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 8 (n=49)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.0" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 10 (n=24)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.0" spread="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 12 (n=47)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.7" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 14 (n=35)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.5" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 16 (n=46)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.8" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 18 (n=42)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.3" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 20 (n=45)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.1" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 22 (n=44)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.8" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 24 (n=44)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.4" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 30 (n=40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.8" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 37 (n=35)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.0" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 50 (n=36)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.3" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 63 (n=26)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.9" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 76 (n=24)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.0" spread="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 89 (n=23)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.6" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 102 (n=15)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0" spread="3.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 115 (n=13)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.1" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 128 (n=11)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.7" spread="2.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 141 (n=10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6.0" spread="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 154 (n=10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.5" spread="2.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 167 (n=10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.5" spread="2.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Changes From Baseline in Heart Rate During the ST + LT Period - Open Label Cohort</title>
        <time_frame>Baseline, Weeks 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 30, 37, 50, 63, 76, 89, 102, 115, 128, 141, 154, 167</time_frame>
        <population>Treated participants; n=number of treated participants with measurement at time point</population>
        <group_list>
          <group group_id="O1">
            <title>Open-Label Treatment Cohort (Direct Enrollees)</title>
            <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
          </group>
        </group_list>
        <measure>
          <title>Changes From Baseline in Heart Rate During the ST + LT Period - Open Label Cohort</title>
          <population>Treated participants; n=number of treated participants with measurement at time point</population>
          <units>beats per minute</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Change from BL at Week 2 (n=62)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.8" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 4 (n=59)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.4" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 6 (n=60)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.3" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 8 (n=49)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.7" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 10 (n=23)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.8" spread="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 12 (n=47)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.0" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 14 (n=34)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.0" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 16 (n=46)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.7" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 18 (n=42)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.0" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 20 (n=45)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.6" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 22 (n=43)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.4" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 24 (n=44)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.4" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 30 (n=40)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 37 (n=35)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.6" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 50 (n=36)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.9" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 63 (n=26)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.0" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 76 (n=24)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.4" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 89 (n=23)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.3" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 102 (n=15)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.3" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 115 (n=13)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 128 (n=11)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.6" spread="3.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 141 (n=10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.4" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 154 (n=10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.5" spread="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from BL at Week 167 (n=10)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.9" spread="3.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Open-Label Treatment Cohort (Direct Enrollees)</title>
          <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>Tablets, Oral, 0mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue)</description>
        </group>
        <group group_id="E3">
          <title>Saxagliptin 10 mg</title>
          <description>Tablets, Oral, 10 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
        </group>
        <group group_id="E4">
          <title>Saxagliptin 2.5 mg</title>
          <description>Tablets, Oral, 2.5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
        </group>
        <group group_id="E5">
          <title>Saxagliptin 5 mg</title>
          <description>Tablets, Oral, 5 mg, Once daily (24 weeks ST, 42 months LT); Metformin 500-2000 mg (as needed for rescue).</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 12.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="11" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="18" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>TACHYCARDIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>ANGINA UNSTABLE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>ATRIAL FIBRILLATION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>AORTIC VALVE STENOSIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>MYOCARDIAL INFARCTION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>CORONARY ARTERY DISEASE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>CARDIAC FAILURE CONGESTIVE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>ACUTE MYOCARDIAL INFARCTION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>SUPRAVENTRICULAR TACHYCARDIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>ADRENAL MASS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>ABDOMINAL PAIN</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>INTESTINAL MASS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN UPPER</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>ABDOMINAL TENDERNESS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>SMALL INTESTINAL OBSTRUCTION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>CHEST PAIN</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>NON-CARDIAC CHEST PAIN</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>CHOLELITHIASIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>GALLBLADDER POLYP</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>CHOLECYSTITIS ACUTE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>GANGRENE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>PNEUMONIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>CELLULITIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>HEPATITIS C</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>APPENDICITIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>TUBERCULOSIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>PYELONEPHRITIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>GASTROENTERITIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>HAEMATOMA INFECTION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>WOUND</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>MULTIPLE FRACTURES</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>DEHYDRATION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>BACK PAIN</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>OSTEOARTHRITIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL PAIN</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>COLON CANCER</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>BRAIN NEOPLASM</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>PROSTATE CANCER</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>CERVIX CARCINOMA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>MALIGNANT MELANOMA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>BASAL CELL CARCINOMA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>RENAL CELL CARCINOMA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>LUNG NEOPLASM MALIGNANT</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>SQUAMOUS CELL CARCINOMA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>SQUAMOUS CELL CARCINOMA OF SKIN</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>SYNCOPE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>SCIATICA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>VASCULAR HEADACHE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>IVTH NERVE PARALYSIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>CEREBROVASCULAR ACCIDENT</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>ABORTION SPONTANEOUS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>NEPHROLITHIASIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>TESTICULAR PAIN</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>BENIGN PROSTATIC HYPERPLASIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>PLEURAL EFFUSION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>CHRONIC OBSTRUCTIVE PULMONARY DISEASE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>RASH</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>HYPOTENSION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>HYPERTENSION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>ORTHOSTATIC HYPOTENSION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA 12.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="39" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="63" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="69" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="72" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="77" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>NAUSEA</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>VOMITING</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="7" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>DIARRHOEA</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="14" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>TOOTHACHE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>CONSTIPATION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="7" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>INFLUENZA</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="15" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="11" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="9" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>SINUSITIS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>BRONCHITIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>PHARYNGITIS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>NASOPHARYNGITIS</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="11" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="13" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>URINARY TRACT INFECTION</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="14" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>UPPER RESPIRATORY TRACT INFECTION</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="12" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="16" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>CONTUSION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>BACK PAIN</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="12" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>ARTHRALGIA</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>PAIN IN EXTREMITY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL PAIN</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>HEADACHE</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="13" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>DIZZINESS</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="9" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>INSOMNIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>DEPRESSION</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="7" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>COUGH</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>OROPHARYNGEAL PAIN</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>RASH</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>HYPERTENSION</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="95"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="102"/>
                <counts group_id="E5" subjects_affected="7" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Boaz Hirschberg</name_or_title>
      <organization>AstraZeneca Pharmaceuticals</organization>
      <email>ClinicalTrialTransparency@astrazeneca.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

